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Abstract
Domestic rabbits have a high risk of anesthesia-related mortality compared to other
companion animals. Factors that may contribute to increased mortality include drug-induced
cardiopulmonary effects (Grint & Murison 2008; Navarrete-Calvo et al. 2013), difficulty
performing intubation (Aeschbacher 1995; Flecknell 2016; Wenger et al. 2017) or damage to
laryngeal and tracheal tissues following orotracheal intubation (Grint et al. 2006; Phaneuf et al.
2006; Engbers et al. 2017).
Alfaxalone is a neuroactive steroid that produces induction of anesthesia and
cardiorespiratory depression in a dose-dependent manner when injected intravenously. The ability
to induce anesthesia via an intramuscular (IM) route has several advantages in the rabbit including
possible reduction in cardiopulmonary adverse effects and reduced stress of handling for
intravenous catheter placement. The dose of alfaxalone needed to produce an adequate plane of
anesthesia to allow intubation has not been evaluated in rabbits. Therefore, one objective of this
research was to determine the optimal dose of IM alfaxalone in combination with
dexmedetomidine and hydromorphone that would allow endoscopic orotracheal intubation of
rabbits. For this chapter, three different doses of alfaxalone (2, 5, and 7 mg kg-1) IM were tested
in combination with 0.1 mg kg-1 hydromorphone and 0.005 mg kg-1 dexmedetomidine. Following
administration of the drug combination containing 7 mg kg-1 alfaxalone, intubation was successful
in 80% of rabbits.
The consequences of repeated intubation attempts using different intubation techniques on
respiratory tissue damage and the potential increase in mortality are largely unknown and have has
not been extensively studied. Therefore, another objective of this research was to compare
respiratory tissue damage caused by blind versus endoscopic-guided intubation of rabbits, and to
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correlate the number of intubation attempts with the degree of respiratory tissue damage. For this
chapter, rabbits were administered 7 mg kg-1 alfaxalone in combination with 0.1 mg kg-1
hydromorphone and 0.005 mg kg-1 dexmedetomidine IM. Intubation was attempted using either
the blind or endoscopic-guided technique. The results demonstrated that blind intubation was
associated with a higher number of intubation attempts; however, no difference in the degree of
tissue damage was observed between the two techniques.

vii

Chapter One. Introduction
The risk of anesthetic-related mortality in companion animals is substantially higher than
that reported in humans undergoing general anesthesia. A large-scale, multi-centric study
conducted in veterinary species determined the overall risk of anesthetic-related mortality to be
0.17% in dogs, 0.24% in cats and 1.39% in rabbits (Brodbelt et al., 2008). Domestic rabbits appear
to be at increased risk of mortality during anesthesia compared to other veterinary species, with
healthy rabbits having a risk of 0.73% and sick rabbits having a risk of 7.37% (Brodbelt et al.,
2008).
Although specific risk factors have yet to be conclusively determined, many studies have
speculated on potential factors that may contribute to this increased risk of mortality seen in
rabbits. As a prey species, the easily stressed nature of domestic rabbits may predispose them to
increased mortality during handling for catheter placement or induction of anesthesia (Flecknell
2016). In addition, many rabbits present with sub-clinical Pasteurella multocida infections which
can predispose them to respiratory complications in the perianesthetic period (Johnson-Delaney &
Orosz 2011; Flecknell 2016). Similar to other companion animal species, drug-induced
cardiorespiratory depression seen with sedatives and anesthetics may also contribute to mortality
(Grint & Murison 2008; Navarrete-Calvo et al. 2013; Bradley et al. 2019). Finally, the ability to
perform orotracheal intubation of rabbits is challenging, often resulting in failure, especially for
personnel with limited experience in this procedure (Grint & Murison 2008; Wenger et al. 2017).
Because of the inherent challenges in orotracheal intubation of rabbits, it is common
practice to perform anesthetic procedures in non-intubated rabbits (Brodbelt 2006; Lee et al. 2018).
Hence, the consequences of drug-induced cardiorespiratory depression may be of greater
importance in rabbits, because they may become more susceptible to, hypoventilation, bradypnea,
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apnea and hypoxemia associated with specific drug combinations (Hellebrekers et al. 1997; Grint
& Murison 2008; Huynh et al. 2014). Thus, anesthetic drug selection may affect mortality rate,
especially in non-intubated rabbits. Many different anesthetic protocols have been described in
rabbits, each offering specific advantages, but also producing variable and potentially severe
adverse effects. The most commonly utilized anesthetic protocols in rabbits include a combination
of a dissociative anesthetic, α-2 agonist, opioid and/or benzodiazepine (Brodbelt 2006). More
recently, alfaxalone has become licenced for use in cats and dogs in the United States among other
countries. Although alfaxalone use in rabbits is still off-label, several studies have emerged
investigating its clinical use and potential adverse effects in rabbits.
Alfaxalone is a synthetic neuroactive steroid that binds to GABA A receptors and facilitates
the inhibitory action of gamma-aminobutyric acid (GABA) resulting in central nervous system
depression (Lambert et al. 2003). Similar to dissociative anesthetics, such as ketamine, alfaxalone
can be administered via the intramuscular (IM) route allowing induction of anesthesia (Marsh et
al. 2009). Many studies have investigated the clinical effects of alfaxalone administered
intramuscularly and have demonstrated that it can provide reliable sedation progressing to
anesthesia with increasing doses in rabbits (Marsh et al. 2009; Huynh et al. 2014; Bradley et al.
2019; Ishikawa et al. 2019). However, dose-dependent respiratory depression, including apnea,
may also occur and are more profound when alfaxalone is combined with other sedative agents
(Navarrete-Calvo et al. 2013; Huynh et al. 2014; Bradley et al. 2019; Ishikawa et al. 2019).
Rabbits are less commonly intubated compared to other companion animals as a result of
the technical challenges associated with intubation and the risk of causing trauma to the fragile
tissues of the upper respiratory tract (Grint et al. 2006; Phaneuf et al. 2006; Engbers et al. 2017).
The challenge in intubating rabbits is largely a result of the unique oropharyngeal anatomy which
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makes it difficult to visualize the larynx and appropriately place an endotracheal tube (Eatwell
2014). As such, several different methods to establish a patent airway in the rabbit have been
described, including variations in blind orotracheal intubation (Krüger et al. 1994; Falcão et al.
2001), endoscopic intubation (Worthley et al. 2000; Tran et al. 2001; Johnson 2010), nasotracheal
intubation (Stephens DeValle 2019), laryngeal mask airway (Smith et al. 2004; Kazakos et al.
2007) and supraglottic airway devices (Crotaz 2010; Uzun et al. 2015).
Few studies have investigated the association between repeated intubation attempts in
rabbits and the occurrence of respiratory tissue damage. Current information is largely based on
anecdotal evidence and case reports. Tracheobronchial injury following blind orotracheal
intubation has been documented; however, a definitive cause of tissue damage could not be
determined, and the number of intubation attempts was not reported in these studies (Grint et al.
2006: Phaneuf et al. 2006). In a prospective randomized experimental study, blind orotracheal
intubation was found to cause more damage to tracheal tissue compared to a supraglottic airway
device (Engbers et al. 2017). In this study, the number of intubation attempts was recorded,
however the degree of tissue damage in relation to histopathology score was not statistically
analyzed. The lack of controlled clinical trials warrants further investigation of the incidence,
etiology and clinical consequences of repeated intubation attempts in rabbits.
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Chapter Two. Literature Review
2.1. Induction of Anesthesia
Rabbits are a commonly anesthetized species and may undergo general anesthesia for a
variety of reasons including diagnostic imaging, surgical procedures, and for research-related
purposes (Brodbelt et al. 2008). However, they also present with one of the highest perianesthetic
mortality rates reported in veterinary species (Brodbelt et al. 2008). Drug-induced
cardiopulmonary depression may be one contributing factor to this increased risk of mortality;
thus, an induction protocol that provides immobility, sedation and anxiolysis while minimizing
cardiovascular depression is ideal. In addition, some authors have speculated that drug dose and
clinical effects may vary depending on the breed, strain, age and health status of the rabbit; thus,
making it difficult to form comparisons among studies or extrapolate data to clinical settings
(Aeschbacher 1995; Cantwell 2001). This phenomenon has been demonstrated. One study has
demonstrated strain-specific and sex-specific differences in response to some anesthetic drugs
(Avsaroglu et al. 2003).
2.1.1. Dissociative Anesthetics
Ketamine is a dissociative anesthetic widely used in veterinary medicine (Akkerdaas et al.
2001; Ferreira et al. 2015). As with other species, ketamine produces dose-dependent sedation and
anesthesia in rabbits; however, it does not provide adequate muscle relaxation (Santos et al. 2016).
Thus, it is often combined with other sedatives and analgesics to induce and maintain general
anesthesia (Flecknell 2016). Several protocols in rabbits have been reported in the literature,
involving ketamine in combination with an α-2 agonist (Borkowski et al. 1990; Hellebrekers et al.
1997; Hedenqvist et al. 2001b; Gil et al. 2002; Difilippo et al. 2004; Henke et al. 2005; Orr et al.
2005; Grint & Murison 2008; Murphy et al. 2010), benzodiazepine (Dupras et al. 2001; Gil et al.
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2002; Hedenqvist et al. 2002; Grint & Murison 2008; Oguntoye et al. 2018) or any combination
of aforementioned drug classes, with or without an opioid.
One study compared induction of anesthesia using four dose combinations of ketamine and
medetomidine in five New Zealand white rabbits (Hedenqvist et al. 2001b). The following doses
of ketamine/medetomidine were administered IM: 25/0.25, 15/0.5, 15/0.25 and 10/0.5 mg kg-1 on
four successive occasions. Induction was smooth and blind orotracheal intubation was achieved
with all doses. Duration of surgical anesthesia (determined by loss of righting reflex) was longer
for dose groups 25/0.25 and 15/0.15 compared to 15/0.25 and only three rabbits achieved surgical
anesthesia in the 10/0.5 groups. Heart rate (HR) and respiratory rate (fR) decreased from baseline
in all groups and was not significantly different between groups. Hypoxemia and hypercapnia
occurred with all doses (Hedenqvist et al. 2001b).
Another study compared induction of anesthesia using IM combinations of ketamine (15
mg kg-1) and medetomidine (0.25 mg kg-1) or ketamine (15 mg kg-1) and midazolam (3 mg kg-1)
in 50 un-premedicated rabbits of various breeds (Grint & Murison 2008). Time to loss of righting
reflex was significantly shorter in the medetomidine group compared to the midazolam group. The
number of intubation failures, number of intubation attempts and quality of intubation was not
different between groups. The HR and hemoglobin oxygen saturation were lower in the
medetomidine group but remained within normal reference ranges (Grint & Murison 2008).
Henke et al. 2005 compared three IM anesthetic induction techniques in 19 chinchilla
mixed-breed rabbits (Henke et al. 2005). Rabbits were administered either medetomidine (0.25 mg
kg-1) and ketamine (35 mg kg-1) or xylazine (4 mg kg-1) and ketamine (50 mg kg-1) or
medetomidine (0.20 mg kg-1), fentanyl (0.02 mg kg-1) and midazolam (1 mg kg-1). All protocols
resulted in loss of righting reflex, but the xylazine-ketamine group had a faster time to loss of
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reflex. A surgical plane of anesthesia was achieved more commonly in rabbits in the
medetomidine-ketamine groups and medetomidine-fentanyl-midazolam groups. Few animals in
the xylazine-ketamine group achieved a surgical plane of anesthesia and duration was significantly
shorter than the other groups. A similar degree of intubation failures occurred among groups.
Rabbits in medetomidine-fentanyl-midazolam group retained the endotracheal tube longer,
without chewing or swallowing reflexes, than the other groups. Heart rates were significantly
higher in the xylazine-ketamine group and the greatest decrease in blood pressure was also
observed in this group. The fR was significantly lower in the medetomidine-fentanyl-midazolam
group with some rabbits experiencing apnea. Hypercapnia was also greatest in this group.
Intramuscular administration may be associated with discomfort and rabbits may react to
injection (Orr et al. 2005; Williams & Wyatt 2007; Grint & Murison 2008). Intramuscular
administration of ketamine has been documented to cause tissue irritation and muscle necrosis
(Aeschbacher 1995). Thus, induction via subcutaneous (SQ) route may be preferred (Wenger
2012). Combinations of ketamine (10-15 mg kg-1 SQ) and medetomidine (0.15-0.25 mg kg-1 SQ)
are sufficient to induce a surgical plane of anesthesia (Hedenqvist et al. 2002; Williams & Wyatt
2007; Grint & Murison 2008) and onset of induction is similar to IM administration of ketamine
and medetomidine (Hedenqvist et al. 2002; Williams & Wyatt 2007). In contrast, Orr et al. 2005
reported a significantly slower onset of induction when similar doses of ketamine-medetomidine
was given SQ compared to IM (Orr et al. 2005).
Telazol is a commercially formulated combination product containing a dissociative
anesthetic (tiletamine) and a benzodiazepine (zolazepam). Studies have reported use of Telazol in
rabbits (Brammer et al. 1991; Popilskis et al. 1991; Dupras et al. 2001). One study in New Zealand
white rabbits reported that high doses (32 or 64 mg kg-1 IM) are required to produce immobility
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(Brammer et al. 1991). In addition, these doses did not blunt the response to noxious stimuli and
were associated with a delayed recovery (Brammer et al. 1991). Furthermore, these doses were
reported to produce dose-dependent renal tubular necrosis within 7 days following injection
(Brammer et al. 1991). Lower doses (7.5 mg kg-1) caused mild renal tubular necrosis (Doerning et
al. 1992). A subsequent study revealed that tiletamine was responsible for the nephrotoxicity of
Telazol in rabbits (Doerning et al. 1992).
2.1.2. Propofol
Propofol is a diisopropyphylphenol hypnotic agent used for IV induction in many
veterinary species (Aono et al. 2001). Initial studies evaluating use of propofol in rabbits
determined that 6 mg kg-1 caused rapid and smooth induction and recovery in non-premedicated
rabbits (Aeschbacher & Webb 1993). However, rabbits appear to be highly sensitive to the
respiratory depressive effects of injectable anesthetics and these drugs should be administered
slowly (Aeschbacher 1995). Apnea may occur even if the drug is administered slowly over 60
seconds (Wenger 2012). Severe respiratory depression appears to occur at the same dose required
for induction, which may interfere with the ability to intubate the rabbit (Aeschbacher & Webb
1993). Dose-dependent hypotension and reflex tachycardia may also occur (Aono et al. 2001).
Propofol is a commonly used IV induction agent in rabbits (Wenger 2012). Relatively high doses
(10-20 mg kg-1) may be needed to induce an anesthetic plane suitable for orotracheal intubation
(Flecknell 2016).
One study evaluated induction of anesthesia using either midazolam or propofol in rabbits
premedicated with fentanyl and fluanisone (Martinez et al. 2009). In this study, both midazolam
and propofol resulted in successful intubation in all but one rabbit. Post-induction apnea was
reported in a significantly higher number of rabbits in the midazolam group compared to the
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propofol group and mean fR was higher in the propofol group. Other hemodynamic variables did
not differ between groups. Time to recover and quality of recovery were significantly better in the
propofol group (Martinez et al. 2009).
A ketamine-propofol (ketofol) combination has been investigated for anesthetic induction
of un-premedicated New Zealand white rabbits (Santos et al. 2016). In that study, three doses of
ketamine and propofol were evaluated. The drugs were mixed together in a 1:1 mg kg-1 ratio so
that each treatment group received either 1, 3 or 5 mg kg-1 each of ketamine and propofol IV. Time
to loss of righting reflex was shortest and the duration of action was longest in the 5 mg kg-1 group.
Loss of righting reflex was not achieved in the 1 mg kg-1 group, nor was intubation possible.
Quality of induction was smooth in the 5 mg kg-1 group and ranged from fair to smooth in the
other groups. Intubation was possible in both 3 and 5 mg kg-1, however intubation quality was
variable. Hypoxemia and dose-dependent respiratory depression was observed in all groups
(Santos et al. 2016). Respiratory depression was also observed following IV induction with S (+)ketamine (1 mg kg-1) and propofol (2 mg kg-1) in New Zealand white rabbits premedicated IM
with acepromazine (0.1 mg kg-1) and buprenorphine (0.02 mg kg-1) and maintained on propofol
alone or in combination with ketamine constant rate infusion (Cruz et al. 2010).
2.1.3. Alfaxalone
Alfaxalone is a synthetic neuroactive steroid that binds to GABAA receptors and facilitates
the inhibitory action of gamma-aminobutyric acid (GABA) resulting in central nervous system
depression (Lambert et al. 2003). The initial formulation of alfaxalone contained a castor oil
surfactant as a solubilizing agent; however, this component resulted in severe anaphylactic
reactions and was later withdrawn from the market (Watt 1975). Years later, alfaxalone was
reformulated with 2-hydroxypropyl-β-cyclodextrin (alfaxalone-HPCD) and did not exhibit
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histamine-releasing properties associated with earlier formulations (West 2017). However, this
new formulation does not include a preservative and according to the USA drug label, once the
vial has been broached, the contents should be drawn into a single syringe and used for a single
patient with any unused product discarded within six hours (Drug insert, Alfaxan®, Jurox Inc.). In
2018, three preservatives were added to alfaxalone-HPCD formulation, resulting in a new product
known as alfaxalone multidose which has an extended shelf life of 28 days following vial
broaching (Drug insert, Alfaxan® Multidose, Jurox Inc.). Currently, alfaxalone-HPCD is licenced
for IV use in cats and dogs in the United States and several other countries (West 2017). Alfaxalone
is also approved for IV use in rabbits in the United Kingdom and Australia and is used off-label in
the United states for induction of anesthesia of rabbits.
Alfaxalone produces induction of anesthesia in a dose-dependent manner when injected
intravenously in rabbits. In one study, administration of alfaxalone to 20 rabbits of various breeds
at doses of 2 or 3 mg kg-1 IV following premedication with buprenorphine at 0.03 mg kg-1 IM
resulted in a smooth and rapid induction of anesthesia with all rabbits achieving an anesthetic plane
sufficient enough to allow blind orotracheal intubation (Grint et al. 2008). However, in another
study performed in New Zealand white rabbits premedicated with IM morphine (1 or 2 mg kg-1)
and medetomidine (0.2 mg kg-1), alfaxalone doses less than 10 mg kg-1 IV provided an insufficient
anesthetic plane to allow orotracheal intubation using an otoscope and guidewire technique
(Navarrete-Calvo et al. 2013).
Alfaxalone produces dose-dependent sedation when injected intramuscularly, with
progression to anesthesia occurring at higher doses (Marsh et al. 2009; Huynh et al. 2014; Bradley
et al. 2019; Ishikawa et al. 2019). Preliminary studies investigating IM administration of alfaxalone
was first performed in wild rabbits (Marsh et al. 2009). In that study, rabbits were premedicated
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with medetomidine (0.25 mg kg-1 SQ), induced with alfaxalone (5 mg kg-1 IM) and maintained
with isoflurane in oxygen (1.5-3%) using a facemask. This protocol resulted in lateral recumbency
in all rabbits and a sufficient anesthetic plane to perform surgical preparation. The authors also
reported smooth induction and uneventful recovery in all rabbits (Marsh et al. 2009).
Administration of IM alfaxalone at doses of 1, 2.5 or 5 mg kg-1 IM resulted in lateral
recumbency and loss of righting reflex in Japanese white rabbits (Ishikawa et al. 2019).
Administration of IM alfaxalone at doses of 4, 6 or 8 mg kg-1 to New Zealand white rabbits resulted
in smooth and rapid onset of sedation and loss of righting reflex, however limb withdrawal in
response to toe pinch was maintained (Huynh et al. 2014). Similarly, administration of IM
alfaxalone 6 mg kg-1 to New Zealand white rabbits resulted in good quality of sedation with smooth
recovery (Bradley et al. 2019). Furthermore, when the same alfaxalone dose was combined with
butorphanol (0.3 mg kg-1 IM) and dexmedetomidine (0.2 mg kg-1 IM), no response to noxious
stimuli occurred, indicating a good anesthetic plane had been achieved. With this drug
combination, the onset of effects was more rapid, and duration was longer compared to alfaxalone
alone (Bradley et al. 2019).
Respiratory depression occurs in a dose-dependent manner following either IM or IV
administration of alfaxalone. Apnea may occur following IV alfaxalone administration, even when
administered slowly over 60 seconds (Grint et al. 2008; Tutunaru et al. 2013; Ishikawa et al. 2019).
Following administration of 3 mg kg-1 IV alfaxalone to un-premedicated New Zealand white
rabbits, RR significantly decreased compared to the control group, however values remained
within normal physiologic limits (Gil et al. 2012).
Dose-dependent respiratory depression and apnea may also occur following IM
administration and is more profound when alfaxalone is combined with other sedative agents
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(Navarrete-Calvo et al. 2013; Huynh et al. 2014; Bradley et al. 2019; Ishikawa et al. 2019).
Evidence of significant respiratory depression is difficult to determine in these studies because
often only fR was measured and more sensitive indices of respiratory function (e.g., hemoglobin
oxygen saturation, capnography, blood gas analysis) were not monitored.
In one study, administration of IM alfaxalone at doses of 4, 6 or 8 mg kg-1 to New Zealand
white rabbits, in absence of other sedatives, caused a dose-dependent decrease in fR (Huynh et al.
2014). In that study, all rabbits experienced a decrease in fR below the normal physiologic value
(defined as fR < 30 breaths minute-1 by the authors). This decrease in fR was significantly greater
and lasted longer in rabbits administered 6 and 8 mg kg-1 compared to those administered 4 mg
kg-1. In addition, the highest dose (8 mg kg-1) resulted in apnea followed by cardiac arrest in one
rabbit (Huynh et al. 2014).
Similar to the study by Huynh et al. 2014, Bradley et al. 2019 also reported a decrease in
fR following administration of 6 mg kg-1 IM alfaxalone to New Zealand white rabbits (Bradley et
al. 2019). In that study, mean fR decreased from 196 ± 7 breaths minute-1 (baseline) to 35 ± 2
breaths minute-1 (10 minutes after injection), representing a decrease in magnitude of greater than
100 breaths minute-1. However, fR remained within the normal acceptable limits (Bradley et al.
2019). In addition, when the same dose of alfaxalone was combined with butorphanol (0.3 mg kg1)

and dexmedetomidine (0.2 mg kg-1), a greater decrease in mean fR occurred (22 ± 3 breaths

minute-1) and this was significantly lower than that of alfaxalone alone (Bradley et al. 2019).
Although hemoglobin oxygen saturation was monitored in this study, there was difficulties
obtaining consistent readings and data were not statistically analyzed.
In another study, decrease in respiratory rate was observed in Japanese white rabbits
following IM administration of alfaxalone at doses of 2.5 mg kg-1 and 5 mg kg-1 but not 1 mg kg-
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(Ishikawa et al. 2019). In this study, the decrease in fR occurred earlier and lasted longer in rabbits

administered 5 mg kg-1 compared to 2.5 mg kg-1 and median minimum fR values were lower for
the 5 mg kg-1 group compared to the 2.5 mg kg-1 group, suggesting a dose-dependent response.
However, at no point did any value decrease below normal physiologic reference range. In
addition, abnormally low (< 95%) hemoglobin oxygen saturation occurred in one rabbit in the 2.5
mg kg-1 group and three rabbits in the 5 mg kg-1 group. For these rabbits, the decrease in
hemoglobin oxygen saturation corresponded with the decrease in fR, suggesting hypoxemia may
have been present (Ishikawa et al. 2019).
Clinically significant hypoxemia (defined as PaO2 < 88 mmHg) has been documented in
New Zealand white rabbits following IM administration of alfaxalone (4 mg kg-1) in combination
with dexmedetomidine (0.1 mg kg-1) and midazolam (0.2 mg kg-1) (Rousseau-Blass & Pang 2020).
In that study 100% oxygen supplementation via facemask resolved the hypoxemia. However, the
increase in PaO2 was associated with a decrease in fR and subsequent hypercapnia (defined as
PaCO2 > 45 mmHg). The authors speculated that drug-induced hypoventilation resulted in
hypoxemia, leading to hypoxic ventilatory drive and increased minute ventilation. Upon provision
of 100% oxygen supplementation, the hypoxic drive was attenuated resulting in a decrease in fR
and hypercapnia associated with drug administration (Rousseau-Blass & Pang 2020).
Alfaxalone exhibits minimal cardiovascular depression in both dogs and cats at clinically
relevant doses administered IV (Muir et al. 2008; Muir et al. 2009). Similar findings have also
been reported in rabbits. In one study, HR significantly decreased following administration of 3
mg kg-1 IV alfaxalone to un-premedicated New Zealand white rabbits compared to the control
group, however values remained within normal physiologic limits (Gil et al. 2012).
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In New Zealand white rabbits, no significant change in HR was observed in rabbits
administered IM alfaxalone at doses of 4, 6 or 8 mg kg-1 (Huynh et al. 2014). Similarly, Ishikawa
et al. 2019 did not observe a significant change in HR or oscillometric blood pressure following
IM alfaxalone administration at doses of 1, 2.5 or 5 mg kg-1 in Japanese white rabbits. However,
HR tended to increase transiently following treatments (Ishikawa et al. 2019). Bradley et al. 2019
also reported no change in HR following administration of 6 mg kg-1 IM alfaxalone to New Zealand
white rabbits (Bradley et al. 2019). However, when the same dose of alfaxalone was combined
with dexmedetomidine (0.2 mg kg-1), the mean HR was lower (146 ± 8 beats minute-1) than the
HR of alfaxalone alone (285 ± 10 beats minute-1) but higher than the HR of dexmedetomidine
alone (133 ± 3 beats minute-1) ten minutes following treatment administration (Bradley et al. 2019).
The authors speculated that the increase in HR observed in the alfaxalone-dexmedetomidine group
compared to the dexmedetomidine group could have been a result of arterial hypotension causing
a reflex increase in HR, however blood pressure was not monitored in this study (Bradley et al.
2019).
2.1.4. Inhalant induction
Inhalant induction through use of a facemask may be considered when IV catheterization
is unsuccessful, IM injectable agents are unavailable, or in situations when the associated stress of
handling is detrimental to the animal. Induction of general anesthesia using volatile anesthetics is
commonly performed using isoflurane or sevoflurane (Eatwell & Mancinelli 2013). The inhalant
is delivered via a tight-fitting face mask or sealed induction chamber and is delivered at a high
concentration of isoflurane (5%) or sevoflurane (8%) in oxygen (Eatwell & Mancinelli 2013).
Induction of anesthesia using inhalants is relatively long compared to rapid-acting intravenous
induction agents (Flecknell et al. 1999). Rabbits may become sufficiently stressed and struggle
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violently during the induction process, potentially leading to spinal and limb injuries (Flecknell et
al. 1999; Eatwell & Mancinelli 2013; Foot 2020). The pungent odour associated with isoflurane
may cause rabbits to breath-hold, resulting in prolonged periods of apnea, leading to hypercapnia,
hypoxemia and respiratory acidosis (Flecknell et al. 1999; Hedenqvist et al. 2001a; Bateman et al.
2005; Longley 2009). However, use of inhalants with a less pungent odour, such as sevoflurane or
desflurane, did not prevent the breath-holding response in rabbits (Flecknell et al. 1999;
Hedenqvist et al. 2001a). Slowly increasing the percentage of anesthetic agent every 30 seconds
does not reduce induction time or the occurrence of breath-holding, anxiety or struggling
(Hedenqvist et al. 2001a). In addition, induction of anesthesia using volatile inhalants is associated
with marked bradycardia (Flecknell et al. 1999; Hedenqvist et al. 2001a).
2.2. Intubation techniques
Orotracheal intubation involves placement of a tube from the oral cavity into the trachea
(Foote 2020). It serves many purposes including effective delivery of inhalational anesthetic gas,
and oxygen supplementation (Nordin 1977). In addition, it provides a patent airway and allows
intermittent positive pressure ventilation when indicated. Furthermore, appropriate airway
management prevents pulmonary aspiration of foreign material and limits personnel exposure to
waste anesthetic gasses.
Both cuffed and uncuffed endotracheal tubes can be used in rabbits. However, uncuffed
tubes may be preferred to prevent damage to tracheal mucosa induced by cuff pressure when
inflated (Nordin 1997). Use of uncuffed tube also allows passage of the largest diameter tube
possible, whereas presence of a cuff increases the outer diameter which may make it too large to
pass through the larynx (Johnson 2010; Flecknell 2016). In addition, cuffed endotracheal tubes
may not be suitable for use in smaller breeds or young rabbits due to lack of availability of smaller
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sized tubes (Johnson 2010). Use of cuffed endotracheal tubes may increase the success rate of
intubation during blind orotracheal intubation of larger breed rabbits (Smith et al. 2004; Lee et al.
2019). Lee et al. 2019 documented an increased risk of failure during intubation of New Zealand
white rabbits when uncuffed tubes were used in comparison to cuffed tubes. The uncuffed
endotracheal tubes used in this study were made of a softer material than the cuffed tubes, and
often bent during blind insertion into the oral cavity preventing further passage of the tube into the
trachea (Lee et al. 2019).
Prior to intubation, an adequate depth of anesthesia should be present, and the arytenoid
cartilages should be desensitized with lidocaine to prevent laryngospasm (Eatwell & Mancinelli
2013; Varga 2014). Endotracheal tube length should be premeasured from the incisors to the
thoracic inlet, to ensure correct placement in the trachea and to avoid endobronchial intubation
(Eatwell & Mancinelli 2013; Thompson 2017; Varga 2017). In addition, airway devices should be
lubricated before use to decrease the risk of trauma to respiratory tissues (Eatwell & Mancinelli
2013). Correct placement of the endotracheal tube in the trachea can be confirmed via,
capnography, respiration monitors, airflow detection devices (e.g., Beck airway airflow monitor),
visualization of condensation on the inside of the endotracheal tube, or by listening for respiratory
sounds at the distal end of the tube (Eatwell & Mancinelli 2013; Thompson 2017; Varga 2017).
Often, elicitation of a cough reflex occurs and indicates passage of the endotracheal tube into the
trachea (Weinstein et al. 2000).
Contrary to canine and feline patients, orotracheal intubation is often difficult to perform
in rabbits as a result of their complex oropharyngeal anatomy (Aeschbacher 1995; Brodbelt 2009;
Stephens De Valle 2009; Crotaz 2010; Flecknell 2016; Varga 2017). The rabbit oral cavity consists
of a small oral commissure and with limited ability to extend the temporomandibular joint. The
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oropharynx is long and narrow, with large incisors and a large fleshy tongue base that impedes
visualization of the glottis (Eatwell & Mancinelli 2013; Varga 2017). The glottis is small and
ventrally situated. Rabbits are obligate nasal breathers, and the epiglottis is normally positioned
dorsally over the soft palate, so the soft palate requires disengagement from the epiglottis in order
to visualize the larynx (Eatwell & Mancinelli 2013; Varga 2017). These anatomical features
greatly hinder direct visualization of the larynx, thus orotracheal intubation can be a challenge in
this species, especially in smaller breeds (Varga 2014). As a result, several different intubation
techniques have been described in the literature in an attempt to provide a technically simplistic,
timely and easily performed method of obtaining a patent airway in the rabbit.
2.2.1. Laryngoscope-Assisted Orotracheal Intubation
In contrast to canine and feline patients, laryngoscope-assisted orotracheal intubation is
comparatively difficult to perform in rabbits, especially in small breed or young rabbits (Varga
2014). Due to the anatomical challenges associated with rabbit intubation, the size of the standard
laryngoscope further impedes visualization of the glottis and hinders placement of an endotracheal
tube (Davis & Malinin 1974). Smaller laryngoscope blades such as Flecknell or Miller (size 00-1)
blades, are appropriate for this technique in rabbits (Gografe et al. 2003; Eatwell & Mancinelli
2013; Thompson 2017; Varga 2017; Lee et al. 2019). Proper positioning is important for successful
intubation often requiring hyperextension of the head and neck causing the larynx to align with
the oropharynx, to allow for direct visualization of the glottis (Inglis and Strunk 2009; Johnson
2010).
The rabbit is positioned in sternal recumbency with the tongue extended to one side of the
oropharynx and grasped with forceps (Eatwell & Mancinelli 2013). The head and neck are then
hyperextended, and the laryngoscope is introduced through the opposite side of the oropharynx.

16

The laryngoscope is positioned to elevate the soft palate dorsally, exposing the glottis and the
endotracheal tube is then passed along the laryngoscope blade and advanced into the trachea
(Eatwell & Mancinelli 2013; Varga 2017). Alternatively, the rabbit can be positioned in dorsal
recumbency to facilitate visualization of the glottis (Eatwell & Mancinelli 2013; Flecknell 2016).
Davies et al. 1996 reported improved visualization of the larynx when attempting intubation from
behind the rabbit positioned in sternal recumbency with the head held upright at a 90° angle to the
surface at which the rabbit was positioned upon (Davies et al. 1996).
A variation to the classic laryngoscope technique involving use of a polypropylene guide
catheter (Seldinger technique) has been described in New Zealand white rabbits (Thompson 2017).
For this technique, the rabbit is placed in sternal recumbency with the head extended dorsally and
the neck extended cranially. The endoscope blade is placed behind the incisors in the left
oropharynx and advanced caudally until the soft palate is visualized. The blade is tipped forward
to compress the base of the tongue and displace the epiglottis and expose the glottis. The guide
catheter is then advanced through the larynx and into the trachea and the endotracheal tube is
advanced over the catheter into the trachea. The laryngoscope and guide catheter are removed and
the endotracheal tube secured in place (Thompson 2017). Similar techniques in New Zealand white
rabbits have also been described in the literature (Macrae & Guerreiro 1989; Gografe et al. 2003).
This technique was found to be simplistic, time efficient and did not require use of specialized
equipment or an assistant (Thompson 2017). However, only large breed rabbits were used in the
aforementioned studies and use of these techniques in young or small breed rabbits may be
challenging as a result of an anatomically smaller oral cavity.
A standard otoscope and ear speculum can be used as an alternative to the laryngoscope
(Eatwell & Mancinelli 2013; Varga 2017) and this may allow better visualization in young or small
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breed rabbits (Weinstein et al. 2000). The otoscope can be used to visualize the glottis as described
for the laryngoscope, or it can be used to position a stylet in the trachea which allows an
endotracheal tube to be advanced over the stylet and into the trachea (Weinstein et al. 2000;
Eatwell & Mancinelli 2013; Varga 2017).
Laryngoscope-assisted intubation is advantageous because equipment is widely available
and inexpensive, and the technique is simplistic and easy to learn. In addition, there is minimal
risk of damage to upper respiratory tissues and successful intubation can be visually confirmed
(Varga 2017). However, aggressive insertion of a laryngoscope may result in injury to the oral
cavity, tongue or teeth (Thompson 2017). Aggressive stylet placement or use of rigid guidewires
may result in damage to the larynx and peri-laryngeal structures (Gografe et al. 2003).
Furthermore, the laryngoscope-assisted technique, with or without use of a guidewire, may not be
suitable for young or small rabbits due to the difficulty in placement of the laryngoscope and
visualization of laryngeal structures (Varga 2014; Thompson 2017). Thus, use of standard
otoscope and ear speculum may be preferred (Weinstein et al. 2000).
2.2.2. Blind Orotracheal Intubation
Blind orotracheal intubation involves placement of an endotracheal tube through the oral
cavity without direct visualization of the glottis (Varga 2017). The classic technique involves
placing the rabbit in sternal recumbency and positioning the head and neck craniodorsally (Fick &
Schalm 1987; Flecknell 2016). The endotracheal tube is inserted blindly into the oropharynx
through the diastema and advanced towards the larynx until respiratory sounds are heard at the
opening of the glottis or condensation is visualized on the inside of the tube, indicating that the
endotracheal tube is correctly positioned at the opening of the glottis. The endotracheal tube is
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advanced into the trachea as the rabbit inhales (Fick & Schalm 1987; Morgan & Glowaski 2007;
Flecknell 2016).
Several variations in the blind technique have been evaluated for efficiency and rapidity of
intubation (Varga 2017). In one such technique, the rabbit was placed in lateral recumbency and
it was demonstrated to be more time consuming to perform and difficult to master compared to
intubation in sternal recumbency (Morgan & Glowaski 2007). Another technique involves
temporary insertion of an endotracheal tube into the esophagus to facilitate blind placement of a
second tube into the trachea (Falcão et al. 2011). This study reported a 100% success rate of
orotracheal intubation in New Zealand rabbits with no reported complications, however the
number of intubation attempts and overall time required to successfully intubate was not reported.
Yet another technique involves blind insertion of a stylet with a small light source attached to the
distal end, placed through the inside of an endotracheal tube (Su et al. 2013). Correct placement
of the stylet at the opening of the glottis was confirmed by anterior neck transillumination causing
a bright glow, at which point the endotracheal tube could be advanced off the stylet into the trachea,
whereas incorrect placement in the esophagus resulted in a dim glow. Intubation was shown to be
faster using the lighted-stylet technique (mean ± SD time 20.34 ± 17.15 seconds) when compared
to laryngoscope-assisted intubation (mean ± SD time 57.58 ± 64.21 seconds) in New Zealand
white rabbits.
One study compared capnography-assisted blind orotracheal intubation to laryngoscopeassisted orotracheal intubation in New Zealand white rabbis and found that the use of capnography
allowed for faster intubation with a higher success rate (Lee et al. 2019). In this study, capnography
was used during the blind orotracheal technique to determine the correct placement of the
endotracheal tube by detecting carbon dioxide in exhaled gas. Use of mainstream capnography
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resulted in rabbits being intubated approximately three times faster compared to sidestream
capnography and approximately eight times faster compared to rabbits intubated using a
laryngoscope. The superiority of the mainstream capnograph in this study was attributed to the
availability of real-time measurements to guide correct placement of the endotracheal tube at the
glottis. Furthermore, a higher intubation success rate was achieved using the blind technique
compared to using a laryngoscope.
The advantage of using the blind technique is that it requires no specialized equipment
(Varga 2017). However, blind orotracheal intubation is technically challenging, time consuming
and requires experience to become efficient (Krüger et al. 1994; Morgan & Glowaski 2007;
Thompson 2017; Varga 2017). It often requires multiple attempts to correctly place the
endotracheal tube, which has been speculated to result in laryngeal and/or tracheal trauma,
hemorrhage, edema or cause laryngospasm (Grint et al. 2006; Phaneuf et al. 2006; Engbers et al.
2017). Because correct placement of the endotracheal tube is reliant on respiration, the occurrence
of hypoventilation or apnea may make it difficult to confirm orotracheal intubation (Thompson
2017). In addition, food material may be inadvertently pushed into the trachea by the endotracheal
tube, potentially causing aspiration pneumonia (Varga 2017).
2.2.3. Endoscopic-Guided Orotracheal Intubation
In absence of specialized equipment, direct visualization of the glottis from the oral cavity
is difficult (Varga 2017). For endoscopic-guided orotracheal intubation, an endoscope, video
laryngoscope or video-optical stylet is used to visualize the larynx and trachea (Johnson 2010).
Typical equipment for endoscopic-guided intubation includes an endotracheal tube, an endoscope
and a light source and potentially a video camera and video display system (Johnson 2010). The
endoscope can be utilized in one of two ways: The side-by-side intubation technique involves
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insertion of the endoscope into the oropharynx and advancing it until the glottal opening is
visualized at which point the endotracheal tube is advanced parallel to the endoscope into the
trachea (Johnson 2010). Alternatively, the over-the-endoscope intubation technique involves
passing the endoscope through the centre of the endotracheal tube and once positioned at the
opening of the glottis, the endotracheal tube is advanced off the endoscope and into the trachea
(Johnson 2010; Eatwell & Mancinelli 2013; Varga 2017).
Many studies have assessed use of endoscopic-guided intubation in rabbits. In one study,
New Zealand white rabbits were placed in dorsal recumbency with the head and neck
hyperextended and a rigid 30° endoscope connected to a light source was used for intubation using
an over-the-endoscope technique (Tran et al. 2001). The authors reported that all 60 rabbits were
rapidly intubated within 30-120 seconds with no instances of incorrect placement in the esophagus
or failed intubation. No complications were reported in the perianesthetic period or long-term. In
addition, no histopathologic evidence of orotracheal injury was present following necropsy at 10
or 30 days (Tran et al. 2001). Another study described use of a semi-rigid 0° fibre-optic endoscope
connected to a light source to intubate dorsally recumbent rabbits using a side-by-side technique
(Worthley et al. 2000). Six New Zealand white rabbits were used, and each was intubated 6 times
followed by euthanasia and necropsy. Mean intubation time was 60.8 ± 8.8 seconds and the
majority of rabbits were successfully intubated on the first attempt. Only 3 of 36 intubation
attempts resulted in esophageal intubation, with the subsequent attempt resulting in correct
placement in the trachea. No complications were reported and there were no gross lesions reported
on post-mortem examination of the oropharynx, other than mild abrasions reported in one rabbit
(Worthley et al. 2000). Similar techniques of endoscopic-guided orotracheal intubation have been
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report with rabbits positioned in sternal recumbency with the head and neck extended and the
mouth held open using a mouth gag placed on the upper and lower jaws (Varga 2017).
The main advantage of endoscopy-guided orotracheal intubation is that it allows direct
visualization of the glottis, which decreases the risk of trauma to laryngeal and tracheal tissues and
allows evaluation of the oropharynx for food or foreign material (Eatwell & Mancinelli 2013;
Varga 2017). Correct placement of the endotracheal tube in the trachea can be visually confirmed
(Johnson 2010). This method is technically simplistic and requires little skill to become efficient
(Worthley et al. 2000; Tran et al. 2001; Johnson 2010). However, specialized equipment is
necessary, expensive and may be of limited availability (Varga 2017).
2.2.4. Nasotracheal Intubation
Nasotracheal intubation involves the insertion of an endotracheal tube into the external
naris, through the nasopharynx and directly into the trachea (Varga 2017). This technique has not
been well described in the literature and only one study, performed by Stephens De Valle 2009,
has assessed feasibility of the technique in rabbits compared to the blind orotracheal approach
(Stephens De Valle 2009). In this study, New Zealand white rabbits were premedicated with
buprenorphine (0.03 mg kg-1 SQ), ketamine (35 mg kg-1 IM), xylazine (5 mg kg-1 IM) and
glycopyrrolate (0.01 mg kg-1 SQ), followed by induction with isoflurane (3.0% in oxygen) via
facemask. The rabbits were then placed in dorsal or sternal recumbency with the head and neck
hyperextended. A lubricated 2.0-2.5 mm uncuffed endotracheal tube was inserted into the external
naris and directed ventromedially into the trachea. Correct placement was confirmed by observing
visualization of condensation inside the tube (Stephens De Valle 2009). The author reported
nasotracheal intubation to be technically easier to perform with less attempts to achieve successful
intubation when compared to blind orotracheal intubation. However, the methodology used to
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perform orotracheal intubation was not described in this study, making it difficult to interpret
results or make comparisons between techniques. It was also reported that endotracheal tubes
placed nasally were less easily dislodged with patient movement when compared to orally placed
tubes. In addition, no complications associated with the nasotracheal technique and no evidence
of respiratory clinical signs were observed during the two-month follow up period (Stephens De
Valle 2009).
Nasotracheal intubation is advantageous as rabbits are obligate nasal breathers and the
epiglottis is naturally engaged with the dorsal soft palate; thus, advancement of the endotracheal
tube through the naris should result in direct access to the trachea (Stephens De Valle 2009; Varga
2017). This technique may be beneficial in smaller rabbit breeds where orotracheal intubation is
difficult or has failed (Varga 2014; Varga 2017). Although not documented in the study by
Stephens De Valle 2009, a potential disadvantage of nasotracheal intubation is an increased risk
of introducing pathogens such as Pasteurella multocida from the nasal cavity into the lungs (Varga
2014; Varga 2017).
2.2.5. Supraglottic Airway Devices
A supraglottic airway device (SGAD) consists of a tube connected to a species-specific,
anatomically shaped cuff (Foote 2020). Insertion of SGADs is easy, rapid and do not require direct
visualization of the larynx for successful placement (Varga 2017). Similar to endotracheal tube
placement, capnography can be used to confirm correct placement of SGADs (Richardson 2015).
When correctly placed, they form a tight seal around the ventral pharynx, larynx and the upper
esophagus (Foote 2020). This allows delivery of oxygen and inhalant anesthetics and allows
sufficient ventilation without intubation of the trachea (Varga 2017). Because these devices do not
engage the larynx or enter the trachea, the risk of tracheal damage and laryngeal spasm is reduced
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(Eatwell & Mancinelli 2013; Varga 2017; Foote 2020). However, lack of direct tracheal seal
increases the risk of gastric tympany or personnel exposure to waste anesthetic gases if the SGAD
becomes dislodged or if the glottis is insufficiently sealed (Varga 2017). Use of SGADs in humans
is associated with an increased risk of gastroesophageal reflux, however this potential complication
has not been documented in rabbits (Valentine et al. 1994). An additional concern is that the lack
of complete air-tight seal hinders use of these devices during positive pressure ventilation (Smith
et al. 2005; Bateman et al. 2005; Wenger et al. 2017).
Many human SGADs are commercially available including laryngeal tubes (LT), laryngeal
mask airway (LMA) and i-gel. Efficient use relies on the device mimicking and conforming to the
specific pharyngeal and peri-laryngeal anatomy of the species it was designed for, thus use of
human SGADs may be less reliable in rabbits due to anatomical differences between the species
(Eatwell & Mancinelli 2013).
An LT consists of a tube containing two cuffs that direct air flow into the trachea, with the
larger proximal cuff forming a seal in the upper pharynx and the smaller distal cuff forming a seal
at the esophageal inlet when inflated (Yamamoto et al. 2007). One study described the blind
insertion of a size 0 LT in New Zealand white rabbits and evaluated its efficacy during positive
pressure ventilation (Yamamoto et al. 2007). The results of this study indicate that the LT was
relatively easy to place with four of six rabbits having the device successfully placed on the first
attempt. For the other two rabbits, device placement was successful on the second attempt.
Efficacy of ventilation was assessed by paralysing the rabbits followed by manual application of
positive pressure ventilation and observing adequate chest movement and by presence of normal
end-tidal carbon dioxide via capnograph. Efficient ventilation was observed in all rabbits. The
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authors report that use of an LT in rabbits was effective for airway management with no
complications reported (Yamamoto et al. 2007).
The LMA consists of a tube connected to an inflatable elliptical mask at the distal end that
forms a seal around the pharynx when inflated (Bateman et al. 2005; Kazakos et al. 2007). For
device placement, the rabbit is positioned in lateral recumbency with the head tilted upward at a
90° angle. The device is turned laterally and placed in the oral cavity with the aperture facing the
tongue and convex side against the buccal wall. The device is advanced blindly until resistance is
met and then is rotated countrerclockwise so that the cuff covers the glottal opening. The cuff is
then inflated to form a seal around the larynx (Smith et al. 2004; Bateman et al. 2005; Kazakos et
al. 2007). Inflation of the LMA has been reported to cause lingual cyanosis due to compression of
the lingual artery (Kazakos et al. 2007).
One study investigated use of an LMA in 50 New Zealand White rabbits weighing between
2.3 and 4.5 kg and demonstrated that the LMA fits well over the rabbit larynx and provides a tight
seal (Kazakos et al. 2007). In addition, device placement was rapid and successful on the first
attempt in all cases. The authors determined that the size 1.0 LMA was more suitable for rabbits
weighing less that 4 kg, whereas the size 1.5 LMA was more suitable for rabbits weighing more
than 4 kg (Kazakos et al. 2007). Four of the rabbits in this study developed lingual cyanosis
following insertion of the LMA. This resolved without complication following deflation of the
cuff in two rabbits, repositioning of the device in one rabbit and using a smaller-sized LMA in the
last rabbit (Kazakos et al. 2007).
Cruz et al. 2000 compared use of a size 1.0 LMA to blind orotracheal intubation in Norfolk
rabbits (2.7 ± 0.4 kg) and evaluated use of the LMA during isoflurane anesthesia and spontaneous
ventilation (Cruz et al. 2000). The results indicated that the LMA was easier and faster to place

25

compared to blind orotracheal intubation. A significantly lower dose of induction agent was
needed to place the LMA and the LMA was successfully placed in all eight rabbits on the first
attempt, whereas only three of eight rabbits were successfully orotracheally intubated on the first
attempt. Hemodynamic variables were similar between groups and no regurgitation or other
complications were reported (Cruz et al. 2000).
Another study evaluated use of a size 1.0 LMA in eight New Zealand white rabbits
(weighing between 3.3 and 5.0 kg) and the ability of the LMA to limit emission of waste anesthetic
gases compared to cuffed and non-cuffed endotracheal tubes (Smith et al. 2004). These authors
also reported that the LMA was easier and faster to place compared to blind orotracheal intubation.
A surgical plane of anesthesia was maintained and no complications such as gastric tympany or
regurgitation were observed with the LMA. Isoflurane concentration was measured at the rabbit’s
oral commissure and in the operator’s breathing zone using an infrared spectrophotometer.
Isoflurane was detected only at the oral commissure for all three devices and a significantly higher
concentration of isoflurane was detected with the LMA compared to both cuffed and non-cuffed
endotracheal tubes (Smith et al. 2004). However, Kazakos et al. 2007 reported no leakage of gas
in the oral commissure during spontaneous or mechanical ventilation of rabbits with an LMA.
Bateman et al. 2005 compared use of a size 1.0 LMA to use of a facemask during isoflurane
anesthesia in spontaneously breathing and mechanically ventilated Giant Flemish cross Chinchilla
rabbits (4.1 ± 0.8 kg). All rabbits anesthetized using a facemask developed signs suggestive of
airway obstruction whereas none of the rabbits in in the LMA groups developed signs of airway
obstruction, indicating that LMAs maintained better airway patency compared to facemasks.
Overall, there was no difference in mean cardiopulmonary variables between spontaneously
ventilating rabbits in the facemask and LMA groups; however, mild hypoxemia (defined as PaO2
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= 70 mmHg) occurred in one rabbit and severe hypercapnia (defined as PaCO2 > 100 mmHg)
occurred in two rabbits, all in the facemask group. Partial pressures of carbon dioxide were
decreased and partial pressures of oxygen were increased in mechanically ventilated rabbits in the
LMA group compared to rabbits that were spontaneously breathing, indicating that positive
pressure ventilation is effective in rabbits with an LMA. Four of six rabbits in the mechanically
ventilated LMA group developed gastric tympany suggesting that the LMA provided an
incomplete seal over the larynx, however the cuffs were not inflated during the study for fear of
causing inguinal cyanosis. In addition, one mechanically ventilated rabbit in the LMA group
regurgitated (Bateman et al. 2005).
More recently, the v-gel, a modified LMA with a non-inflatable cuff, has been designed
for use in rabbits (Crotaz 2010). The device consists of a plastic tube with a tapered end that is
inserted into the pharynx and lodges over the glottis, forming a seal around the opening of the
larynx (Varga 2017). The device is manufactured with silicone material which is unlikely to cause
damage to pharyngeal structures and the material does not harden following cleaning or
sterilization (Eatwell & Mancinelli 2013). In addition, these devices come in a variety of sizes and
conform to the specific anatomy of the rabbit airway, thus proper placement should prevent
aspiration of gastric contents and allow intermittent positive pressure ventilation without leakage
of waste anesthetic gases (Crotaz 2013; Eatwell & Mancinelli 2013; Wenger et al. 2017). During
insertion, the device deflects the soft palate dorsally to disengage the epiglottis (Eatwell &
Mancinelli 2013). The rabbit is placed in sternal recumbency and the tongue is extended outside
the mouth. An appropriately sized v-gel is blindly inserted into the oral cavity until the baffle plate
at the end of the device is placed between the upper and lower incisors and correct placement is
confirmed using capnography (Crotaz 2013).
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A preliminary feasibility study on use of an i-gel in rabbits was performed using five
cadaver rabbits (Crotaz 2010). Modifications of the device allowing it to conform the specific
pharyngeal and laryngeal anatomy of the rabbit, lead to the development of a rabbit-specific v-gel.
(Crotaz 2010). Since then, investigations on the clinical use of the rabbit v-gel have demonstrated
a high success rate. However, the device was again redesigned to allow easier insertion and
placement (Crotaz 2013). This redesigned v-gel was clinically tested in 29 rabbits undergoing
anesthetic procedures and the v-gel was easily and rapidly placed in 27 of these rabbits with a
mean insertion time of 8 seconds. During the anesthetic period, hemodynamic variables remained
within clinically acceptable limits. No respiratory complications were noted, however mild lingual
cyanosis was reported in one rabbit which resolved with jaw manipulation and repositioning of the
device. It was speculated that lingual cyanosis was a result of compression of the tongue and
subsequent venous congestion rather than arterial compression. It was also noted that the v-gel
became easily dislodged if the patient is repositioned following placement. Based on this initial
assessment, the v-gel design was again modified to reduce the incidence of these problems (Crotaz
2013). For these two studies, both failed to mention specific characteristics of the rabbits utilized
(e.g., breed, weight, age). Therefore, it is difficult to determine clinical applicability based on these
assessments alone.
Following the initial studies performed by Crotaz 2010 and 2013, several other studies
have investigated use of the v-gel in rabbits. Many studies have reported that the rabbit v-gel is
faster to place with less attempts when compared to blind orotracheal intubation (Richardson 2015;
Engbers et al. 2017), laryngoscope-assisted orotracheal intubation (Uzun et al. 2015), endoscopicguided orotracheal intubation (Comolli et al. 2020) and LMA insertion (Uzun et al. 2015). Lingual
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cyanosis is a common complication associated with v-gel use; however, this is typically resolved
with repositioning of the device (Richardson 2015; Uzun et al. 2015; Wenger et al. 2017).
2.2.6. Facemasks
Successful intubation may require excess time, multiple intubation attempts, and ultimately
may result in failure to intubate (Smith et al. 2004; Grint & Murison 2008; Richardson 2015;
Wenger et al. 2017). Thus, as a result of the difficulties associated with orotracheal intubation,
alternate methods of administering inhalant anesthetic agents and oxygen supplementation are
often used in the rabbit (Foote 2020). Anesthetic maintenance via facemask is the most simplistic
method of providing general anesthesia; however, it is associated with a number of disadvantages.
Use of facemasks may not allow for adequate oxygenation or ventilation during anesthesia
and does not ensure maintenance of a patent airway which may predispose to airway obstruction
(Bateman et al. 2005). In addition, use of a facemask can increase exposure of anesthetic gases to
personnel (Bateman et al. 2005; Eatwell & Mancinelli 2013). Trace inhalant concentration
exposure in humans may be associated with detrimental effects such as damage to chromosomes
and developmental abnormalities in utero during pregnancy and cognitive issues (Hoerauf et al.
1999; Smith et al. 2004; Nilsson et al. 2005).
2.3. Respiratory Tissue Trauma
Damage to laryngeal and tracheal tissues following orotracheal intubation has been
documented in rabbits; however, causes for this damage are largely unknown (Grint et al. 2006;
Phaneuf et al. 2006; Engbers et al. 2017). Compared to other veterinary species, rabbits may be
more prone to laryngeal and tracheal trauma as a result of a highly vascularized mucosa and
submucosa (Phaneuf et al. 2006). Contact of the endotracheal tube with the larynx and trachea may
result in tracheal irritation leading to vascular congestion, edema and hemorrhage (Phaneuf et al.
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2006). Severe lesions may result in tracheal stricture formation with clinical signs becoming
evident days later (Grint et al. 2006).
Potential causes of laryngeal and tracheal trauma have been widely speculated and include
aggressive intubation or multiple intubation attempts (Phaneuf et al. 2006), movement of the
endotracheal tube during patient positioning (Grint et al. 2006; Phaneuf et al. 2006) or during
mechanical ventilation (Phaneuf et al. 2006) and chemical burns caused by disinfectant residues
following endotracheal tube sterilization (Grint et al. 2006). Improperly secured endotracheal tubes
may result in movement or rotation of the tube within the trachea causing trauma to laryngeal and
tracheal tissues (Eatwell & Mancinelli 2013).
One case series documented three reports of tracheobronchial stricture formation in rabbits
during post-mortem evaluation following a previous anesthetic event in which the rabbits
underwent blind orotracheal intubation (Grint et al. 2006). All three rabbits recovered from
anesthesia uneventfully; however, all rabbits developed dyspnea and clinical signs of dyspnea 1724 days later. A definitive cause was never identified following gross and histopathological
examination (Grint et al. 2006). It is possible that trauma induced by the endotracheal tube could
have resulted in stricture formation as evidenced by experimental studies using a nylon brush to
mimic endotracheal tube trauma in rabbits and resulting in tracheal stricture formation within 14
days of the experiment (Nakagishi et al. 2005; Steehler et al. 2011). A second case series evaluated
gross and histologic damage to laryngeal and tracheal tissues documented in 15 New Zealand
white rabbits following anesthesia where rabbits underwent blind or endoscopic-guided
orotracheal intubation (Phaneuf et al. 2006). Six of these rabbits developed respiratory clinical
signs in the post-anesthetic period, of which two rabbits acutely died and one was euthanized due
to ongoing clinical signs. The remainder of rabbits (including three rabbits that developed mild
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respiratory clinical signs) were euthanized for research-related purposes, unrelated to respiratory
disease. Post-mortem examination of the 15 rabbits revealed a wide range of gross and
histopathological lesions of laryngeal and tracheal tissues, however causative factors were not
definitively identified (Phaneuf et al. 2006).
Another study compared blind orotracheal intubation and insertion of a v-gel in 15 New
Zealand white rabbits and evaluated damage to respiratory tissues caused by these techniques
(Engbers et al. 2017). They concluded that placement of a v-gel causes less histological trauma to
tracheal tissues compared to blind orotracheal intubation. In addition, all rabbits were successfully
intubated using the blind technique after one or two attempts, indicating that single attempts at
intubation can result in sufficient tracheal injury (Engbers et al. 2017). A more recent study
compared endoscopic-guided orotracheal intubation and insertion of a v-gel in 14 New Zealand
white rabbits and evaluated gross and histological damage to laryngeal and tracheal tissues
(Comolli et al. 2020). The results indicated that histological evidence of damage was present
following intubation with both techniques, however degree of damage was similar between groups
(Comolli et al. 2020).
Ancillary intubation equipment may also result in respiratory tissue damage. In one study,
three of six rabbits experienced respiratory clinical signs following laryngoscope-assisted
orotracheal intubation and use of a rigged, plastic-coated wire stylet (Gografe et al. 2003). One
rabbit developed pulmonary edema, evidenced by marked serosanguinous fluid aspirated from the
endotracheal tube, following observed laryngeal trauma during stylet placement. This rabbit
became dyspneic and was euthanized. The second rabbit experienced laryngeal trauma during
intubation, resulting in pulmonary edema and wheezing pulmonary rales but recovered following
supportive therapy. The third rabbit developed dyspnea with inspiratory and expiratory stridor
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following extubation with wheezing and crackles present on pulmonary auscultation. This rabbit
became opisthotonic and died before emergency measurements could be undertaken. After
switching to a flexible guidewire, the remaining 33 animals in the study were intubated without
complication (Gografe et al. 2003).
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Chapter Three. Assessment of Three Doses of Intramuscular Alfaxalone
Combined with Hydromorphone and Dexmedetomidine to Allow EndoscopicGuided Orotracheal Intubation in Domestic Rabbits (Oryctolagus Cuniculus)
3.1. Introduction
Domestic rabbits have a 1.39% risk of anesthetic-related mortality compared to 0.17% and
0.24% in dogs and cats respectively (Brodbelt et al. 2008). Drug-induced cardiorespiratory
depression may be one factor contributing to this increased risk. Intubation is inherently difficult
in rabbits and the use of injectable sedatives and anesthetics (opioids, benzodiazepines, α-2
adrenergic agonists, dissociative anesthetics) is often necessary to facilitate intubation by
providing sedation, immobilization and muscle relaxation (Borkowski & Karas 1999). Specific
drug combinations such as medetomidine and ketamine are associated with variable and
potentially severe adverse effects warranting the investigation of safer alternatives (Hellebrekers
et al. 1997; Grint & Murison 2008).
Alfaxalone is a synthetic neuroactive steroid that binds to GABA A receptors and facilitates
the inhibitory action of gamma-aminobutyric acid (GABA) resulting in central nervous system
depression (Lambert et al. 2003). It is formulated with 2-hydroxypropyl-β-cyclodextrin
(alfaxalone-HPCD) and licenced for intravenous (IV) use in cats and dogs in the United States and
other countries. Alfaxalone is also approved for IV use in rabbits in the United Kingdom and
Australia. Intramuscular (IM) administration is approved for cats in Australia however off-label
IM use is common in other species.
Several studies have investigated the sedative and anesthetic effects of IM alfaxalone in
rabbits. In one study, IM alfaxalone was administered at doses of 4, 6 or 8 mg kg-1 to New Zealand
white rabbits (Huynh et al. 2014). All doses resulted in smooth and rapid onset of sedation and
dose-dependent respiratory depression; however, one rabbit receiving 8 mg kg-1 experienced apnea
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followed by cardiac arrest. Another study in New Zealand white rabbits, reported good quality of
sedation with smooth recovery and minimal cardiorespiratory depression following administration
of 6 mg kg-1 alfaxalone IM as a sole agent (Bradley et al. 2019). Furthermore, when the same dose
was combined with butorphanol (0.3 mg kg-1 IM) and dexmedetomidine (0.2 mg kg-1 IM), no
response to noxious stimuli occurred, indicating a good anesthetic plane had been achieved. With
this drug combination, the onset of effects was more rapid, and duration was longer compared to
alfaxalone alone. There was also a greater magnitude of cardiovascular and respiratory depression,
however values remained within normal limits (Bradley et al. 2019).
Intravenous administration of alfaxalone at 2 or 3 mg kg-1 following premedication with
buprenorphine at 0.03 mg kg-1 IM has been shown to result in a smooth and rapid induction of
anesthesia with minimal cardiorespiratory effects and a high success rate of blind orotracheal
intubation in rabbits (Grint et al. 2008). However, there is currently no data evaluating the
suitability of IM alfaxalone for orotracheal intubation of rabbits. Induction of anesthesia using IM
alfaxalone is advantageous due to less handling and associated stress with catheter placement for
IV administration, in addition to it being a non-controlled substance with limited abuse potential.
The objective of this study was to determine the dose of IM alfaxalone combined with
dexmedetomidine and hydromorphone that would allow endoscopic-guided orotracheal intubation
of rabbits without causing a decrease in respiratory rate (fR) and/or apnea. We hypothesized that
when administered IM with hydromorphone (0.1 mg kg-1) and dexmedetomidine (0.005 mg kg-1),
increasing the dose of alfaxalone (2, 5 or 7 mg kg-1) would increase the success rate of endoscopicguided orotracheal intubation but would progressively depress respiratory rate and/or increase the
occurrence of apnea.
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3.2. Materials and Methods
3.2.1. Animals
This study was approved by the Louisiana State University (LSU) Institutional Animal
Care and Use Committee (Protocol No. 17-101). Fifteen intact, Miniature Lop rabbits were used
for this study. There were 9 females and 6 males, ranging from 4 to 9 months in age and weighing
a mean ± SD of 2.3 ± 0.3 kg. Rabbits were deemed healthy based on results of physical
examination, complete blood count and serum biochemical analysis. Upon arrival, rabbits were
housed separately in pens grouped by sex and allowed to acclimatize for at least two weeks prior
to the experimental period. They had free access to fresh water and Alicia or Alfalfa hay and were
fed a commercial pelleted diet (Country Acres Rabbit Pellet 16%, Country Acres Feed Company,
MN, USA) twice daily. Food, but not water, was withheld 12 hours prior to the experiment.
At the completion of the study, male rabbits were neutered by the Louisiana State
University Division of Laboratory Medicine personnel and all rabbits were made available for
adoption.
3.2.2. Experimental Design
For each rabbit, age, sex, weight, and fR were recorded at the beginning of the experimental
period (T = 0). Rabbits were randomly assigned using a random number generator
(www.randomnumbergenerator.com) to one of three treatment groups (n = 5 per group). All
rabbits were administered 0.1 mg kg-1 hydromorphone (Hydromorphone Hydrochloride; Hospira
Inc., IL, USA) and 0.005 mg kg-1 dexmedetomidine (Dexdormitor; Zoetis Inc., MI, USA)
combined with one of three doses of alfaxalone (Alfaxan multidose; Jurox Inc., MO, USA): low
dose alfaxalone (A2; 2 mg kg-1), mid dose alfaxalone (A5; 5 mg kg-1) and high dose alfaxalone
(A7; 7 mg kg-1). Drug selection and doses used were based on clinical use at the LSU veterinary
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teaching hospital and by conducting a pilot study using two rabbits. The drugs were mixed together
immediately prior to injection and administered intramuscularly into the semimembranosus or
semitendinosus muscles of the right or left hindlimb of each rabbit by the same investigator
(PQW).
Rabbits were placed in a small animal carrier, under observation, for 10 minutes to allow
for maximal sedative effects. Subsequently, fR was recorded (T = 10) and quality of anesthesia was
subjectively evaluated using a semi-quantitative rating scale modified from Raekallio et al. 2002
(Appendix A.1). The rating scale consisted of 5 categories and their scores were summed for a
total anesthesia score ranging from 0 to 12: spontaneous posture (0-4), response to toe pinch (02), palpebral reflex (0-2), eye rotation (0-1) and jaw tone (0-3). The investigator assessing the
anesthesia quality score (SNR) was blinded to the treatment group. Rabbits were then positioned
in sternal recumbency with the head and neck extended and 2 mg of Lidocaine (Lidocaine
Injectable, 2%; Vetone, ID, USA) was blindly splashed over the arytenoids. Thirty seconds later,
orotracheal intubation was attempted by the same investigator (PQW) using an uncuffed, 2.0 mm
inner diameter, murphy-eyed endotracheal tube (Mallinckrodt Pharmaceuticals, MO, USA) placed
over a semi-rigid endoscope (FM-1.9X6 Micro-Endoscope; MDS-VET, Canada). Once the
endoscope was inserted into the trachea, the endotracheal tube was advanced off the endoscope
and into the trachea. Only one intubation attempt was performed per animal. An intubation attempt
was defined as the advancement of the endotracheal tube from the mouth, at the level of the
incisors, to the opening of the larynx. End-tidal partial pressure of carbon dioxide was measured
using a multiparameter monitor (CARESCAPE monitor B850; GE Healthcare, Finland).
Intubation was considered successful when up to 6 consecutive end-tidal carbon dioxide readings
were present on the capnograph and considered unsuccessful if no readings were present. For
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rabbits that were intubated, quality of intubation was subjectively evaluated by one investigator
(PQW) using a semi-quantitative rating scale ranging from 0 to 3 (Appendix A.2).
Immediately following the end of the experiment, male rabbits were placed under general
anesthesia with isoflurane in 100% oxygen for orchiectomy. Female rabbits were immediately
extubated. All rabbits recovered under supervision and were placed back in their pen once they
regained the ability to ambulate.
3.2.3. Statistical Analysis
Statistical analysis was performed with commercially available software (JMP Pro 15.0.0,
SAS Institute Inc., NC, USA). One-way ANOVA was used to analyze the continuous response
variable (weight) with the treatment group as the fixed effect. Respiratory rates at time 0 and 10
minutes were compared with a paired-t test. Assumptions of these models (linearity, normality of
residuals and homoscedasticity of residuals) and influential data points were assessed by
examining standardized residual and quantile plots and the normality of residual was confirmed
with Shapiro-Wilk test. Ordinal scores (intubation and anesthesia quality scores) were analyzed
by Kruskal-Wallis test followed by post hoc pairwise comparisons. Sex against treatment groups
was tested with Fisher’s exact test. Values of P < 0.05 were considered significant. Non-normally
distributed data are reported in median (range).
3.3. Results
All rabbits completed the study without any adverse events. There were no significant
differences in sex or weight between rabbits of the three groups. Respiratory rates were
significantly lower at T = 10 compared to T = 0 (P < 0.001) for all treatment groups (Table 1). No
apnea occurred in any rabbit in any treatment group.
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Table 1. Respiratory rate data (breaths per minute; median (range)) at baseline and 10 minutes
after administration of dexmedetomidine (0.005 mg kg-1), hydromorphone (0.1 mg kg-1), and either
alfaxalone 2 mg kg-1 (group A2), 5 mg/kg (group A5), or 7 mg kg-1 (group A7).

Baseline (T = 0)
10 min after injection (T = 10)

Group A2
160 (100-240)
72 (28-168)

Group A5
180 (160-210)
36 (28-68)

Group A7
170 (120-200)
40 (32-48)

The median total anesthesia quality scores for the A2, A5 and A7 treatment groups were 3
(2-5), 6 (5-6) and 6 (4-9), respectively (Table 2). Rabbits in treatment groups A7 (P = 0.04) and
A5 (P = 0.02) had significantly higher total anesthesia quality scores compared to rabbits in group
A2.
Table 2. Median (range) anesthesia quality scores in rabbits following administration of
dexmedetomidine (0.005 mg kg-1), hydromorphone (0.1 mg kg-1) and either alfaxalone 2 mg kg-1
(group A2), 5 mg kg-1 (group A5), or 7 mg kg-1 (group A7). The maximum possible anesthesia
quality score is 12. * Indicates significant difference (P < 0.05) from group A2.

Spontaneous posture
Response to toe pinch
Palpebral reflex
Eye rotation
Jaw tone
Total anesthesia score

Group A2
1 (1-2)
0
1 (0-1)
0
1 (1-2)
3 (2-5)

Group A5
2 (2-2)
0
1 (1-1)
0
3* (2-3)
6* (5-6)

Group A7
3* (2-4)
0
1 (1-2)
0
2*(2-3)
6* (4-9)

The median values for each category of the anesthesia quality score for each treatment
group are presented in Table 2. Group A7 had a significantly higher spontaneous posture score
compared to A2 (P = 0.03). Jaw tone score was significantly higher in group A7 and A5 when
compared to A2 (P = 0.02 and P = 0.02, respectively). Scores for response to toe pinch, palpebral
response, and eye rotation were not significantly different between groups.
Successful intubation occurred in 0/5 (0%), 3/5 (60%), and 4/5 (80%) of rabbits with
median intubation quality scores of 0 (0-0), 2 (0-3) and 2 (0-3) in the A2, A5 and A7 treatment
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groups, respectively. Treatment group A7 had significantly higher intubation quality scores
compared to group A2 (P = 0.02).
3.4. Discussion
This study demonstrates that IM alfaxalone in combination with hydromorphone and
dexmedetomidine causes dose-dependent anesthetic induction of rabbits, facilitating endoscopicguided orotracheal intubation with minimal changes in respiratory rate.
The total anesthesia quality scores for rabbits in treatment groups A5 or A7 were similar,
and higher than rabbits in treatment group A2. This indicates a dose-dependent effect progressing
from mild sedation to anesthesia. For each dose, the onset of effects following IM alfaxalone
injection was smooth and rapid, with maximal sedative effects occurring within 10 minutes of
injection. These findings are similar to those reported in other studies (Huynh et al. 2014; Ishikawa
et al. 2019).
Lateral recumbency (as indicated by spontaneous posture score) was achieved only in
treatment group A7, whereas rabbits in groups A2 or A5 remained in sternal recumbency. This is
in contrast to data reported by Huynh et al. 2014, who reported rapid loss of consciousness and
loss of righting reflex in rabbits administered a single dose of either 4, 6, or 8 mg kg-1 alfaxalone
IM. Ishikawa et al. 2019 also reported lateral recumbency and loss of righting reflex at lower doses
(1, 2.5 or 5 mg kg-1 IM) of alfaxalone than the doses used in the current study. Furthermore, it was
expected that addition of hydromorphone and dexmedetomidine in the current study had an
additive or synergistic effect on level of sedation compared to alfaxalone alone. One reason for the
observed differences seen is based on methods used to evaluate spontaneous posture. Both
aforementioned studies evaluated loss of righting reflex by positioning the rabbits in lateral or
dorsal recumbency and documenting the resistance of the animals trying to obtain an upright
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position. In the current study, spontaneous posture was assessed without interference by human
handling or positioning of the subjects. It is possible that if rabbits in treatment groups A2 or A5
were placed in lateral recumbency, loss of righting reflex may have been observed.
Jaw tone scores for treatment groups A5 and A7 were similar and higher than that of
treatment group A2. Decreased jaw tone at these higher doses provided sufficient muscle
relaxation to facilitate opening the mouth and this was likely a contributing factor to successful
intubation in these rabbits. Ishikawa et al. 2019 reported poor or slight jaw relaxation in rabbits
administered 1 or 2.5 mg kg-1 IM alfaxalone (poor) or 5 mg kg-1 IM alfaxalone (slight); whereas
the current study reports minimal or no jaw tone at 5 or 7 mg kg-1 IM alfaxalone with
hydromorphone and dexmedetomidine. This suggests that alfaxalone alone may not provide
sufficient jaw relaxation to allow intubation and higher doses and the addition of muscle relaxants
such as α-2 agonists or opioids may be necessary to increase the success rate of intubation. Even
though jaw tone scores were similar for treatment groups A5 and A7, group A7 had a higher
success rate of intubation (80% vs. 60%). As previously mentioned, group A7 rabbits exhibited a
higher spontaneous posture score indicating a deeper plane of anesthesia, which likely contributed
to the greater success rate of intubation in group A7.
All rabbits responded to the toe pinch with a complete withdrawal of the forelimb,
indicating that response to noxious stimulation was still present at all alfaxalone doses tested.
These findings are in accordance with other studies assessing a withdrawal response following a
single IM injection of alfaxalone at similar doses in rabbits (Bradley et al. 2019; Huynh et al.
2014). However, in the study by Bradley et al. 2019, when alfaxalone (6 mg kg-1) was combined
with butorphanol (0.3 mg kg-1) and dexmedetomidine (0.2 mg kg-1) and administered IM, the
withdrawal response was consistently absent. This suggests that sufficient muscle relaxation and
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analgesia was present in the drug protocol to suppress noxious stimulation associated with the toe
pinch. This lack of response could possibly be a result of the relatively high dose of
dexmedetomidine used, which provides dose-dependent analgesia in addition to muscle relaxation.
In the current study, the dose of dexmedetomidine was comparatively lower than that used in the
previous study by Bradley et al. 2019 and may have not been sufficient to abolish the toe pinch
withdraw.
Variable doses of IV alfaxalone allowing for orotracheal intubation have been reported,
ranging from 2 mg kg-1 to 10 mg kg-1 (Grint et al., 2008; Navarrete-Calvo et al. 2013). These
differences may reflect age-related and/or breed-specific characteristics and type or dose of
premedication used. Rabbits are frequently difficult to intubate, and this is largely a result of their
unique oropharyngeal anatomy (Varga 2017). They have a long, narrow oral cavity with a large,
fleshy tongue and large incisors, making visualization of the larynx difficult. As such, an adequate
plane of anesthesia to allow proper extension of the head and opening of the mouth, is required to
visualize the larynx with a scope and to facilitate intubation. In this study, none of the rabbits in
treatment group A2 could be intubated. However, 60% of rabbits in treatment group A5 and 80%
of rabbits in A7 could be successfully intubated, representing a 20% increase in intubation success
rate. Based on this dose-related progression, we speculate that doses greater than 7 mg kg-1 may
further increase the success rate of intubation; however, the risk of respiratory complications such
as hypoventilation and/or apnea may also increase in a dose-dependent fashion, and further studies
are needed to ascertain these risks. In addition, increasing doses of alfaxalone will increase the
total injectate volume. With the only currently available concentration (10 mg ml-1) of alfaxalone,
larger doses may become impractical to inject or result in pain or discomfort, as is the case in dogs
and cats (Grubb et al. 2013; Tamura et al. 2016).
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Even though rabbits in the treatment groups A5 and A7 exhibited similar total anesthesia
quality scores, a higher percentage of rabbits were successfully intubated in the A7 treatment
groups versus the A5 treatment group (80% vs. 60%). Rabbits within the A5 treatment group had
lower individual total anesthesia score values (maximum score = 6/12) and overall a narrow range
of values (5-6), whereas rabbits within the A7 treatment group had higher individual total
anesthesia score values (maximum score = 9/12) and a wider range of values (4-9), resulting in
similar median total anesthesia scores.
Intravenous administration of alfaxalone can cause apnea in dogs and cats, especially
following rapid IV administration (Muir et al. 2009; Amengual et al. 2013; Bigby et al. 2017). In
rabbits, apnea was also shown to occur, even when IV alfaxalone was administered slowly over a
period of 60 seconds (Grint et al. 2008; Tutunaru et al. 2013; Ishikawa et al. 2019). In contrast, IM
alfaxalone is less likely to cause apnea, presumably due to slower drug uptake and absorption;
however clinically significant, dose-dependent respiratory depression may occur, especially when
other sedative agents are used in combination (Navarrete-Calvo et al. 2013; Huynh et al. 2014;
Bradley et al. 2019; Ishikawa et al. 2019). In the current study, no apnea occurred. However,
respiratory rates were lower following administration of all three drug protocols but remained
within normal physiologic values (30-60 breaths minute-1) for rabbits (Meredith & Crossley 2002).
These results are in agreement with other studies evaluating similar doses of alfaxalone IM (Marsh
et al. 2009; Ishikawa et al. 2019). The reasons for the decreased respiratory rates reported in some
studies and the lack of respiratory adverse effects observed in others, including this study can only
be speculated, and may be a result of several factors such as: differences in breed-specific or strainspecific drugs sensitiveness, age- or sex-related factors, environmental factors (e.g., stress, study
design) and presence of underlying or sub-clinical disease.
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Several limitations were identified in the current study. Bias could have been introduced
into the study design as the investigator performing intubation (PQW) was aware of the treatment
group. In addition, only young and healthy Mini-Lop rabbits were used in this study, indicating
that results can only be applied to this subset of animals. Potential differences in drug-related
effects may arise in older rabbits, different breeds of rabbits, or rabbits with clinical illness or
underlying disease. The suitability of drug protocols tested in the current study were only evaluated
for endoscopic-guided orotracheal intubation, when in fact there are several intubation techniques
employed in rabbits. The intubation success rates with different techniques could vary with the
drug protocols used in this study. Finally, the evaluation of respiratory depression in this study
was only based on respiratory rate and presence or not of apnea, while other methods of respiratory
function monitoring, such as capnography and blood gas, would provide better measurements of
the depressant effects on ventilation and oxygenation.
In conclusion, when administered with 0.1 mg kg-1 hydromorphone and 0.005 mg kg-1
dexmedetomidine, increasing doses (2, 5, 7 mg kg-1) of IM alfaxalone progressively increased the
success rate of endoscopic-guided orotracheal intubation. Furthermore, increasing the dose of
alfaxalone had no significant effect on respiratory rate. Higher doses of alfaxalone and/or
dexmedetomidine may be necessary to increase the success rate of endoscopic-guided orotracheal
intubation.
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Chapter Four. Comparison of Endoscopic-Guided and Blind Orotracheal
Intubation Techniques and their Correlation with Anesthesia Quality and
Respiratory Tissue Damage in Domestic Rabbits (Oryctolagus Cuniculus)
4.1. Introduction
Domestic rabbits are amongst the most commonly anesthetized companion animal species
(Brodbelt et al. 2008). However, the reported 1.39% overall risk of anesthetic-related mortality is
much higher than that reported in dogs (0.17%) and cats (0.24%) (Brodbelt et al. 2008). Several
factors may contribute to the increased risk including drug-induced cardiorespiratory depression
(Grint & Murison 2008; Navarrete-Calvo et al. 2013; Bradley et al. 2019), difficulty of intubation
(Grint & Murison 2008; Wenger et al. 2017), damage to respiratory tissues during intubation (Grint
et al. 2006; Phaneuf et al. 2006; Engbers et al. 2017) and underlying, subclinical respiratory disease
(Johnson-Delaney & Orosz 2011).
Rabbit intubation can be challenging and one possible reason may be a result of their
complex oropharyngeal anatomy. The oral cavity of the rabbit is small consisting of a large, fleshy
tongue and large incisors. In addition, the oropharynx is long and narrow with a ventrally situated
glottis (Eatwell 2014). These anatomical features hinder visualization of the larynx and make
orotracheal intubation technically challenging.
Amongst the many intubation techniques described in rabbits, blind orotracheal intubation
is one of the most commonly utilized in clinical practice as it requires no specialized equipment
(Varga 2017). However, because direct visualization of the larynx is not achievable, repeated
attempts may be necessary for successful intubation. Multiple intubation attempts may result in
trauma to the delicate tissues of the larynx and trachea (Phaneuf et al. 2006). Endoscopic-guided
intubation may facilitate visualization of the larynx and minimize the number of intubation
attempts potentially resulting in less risk of respiratory tissue damage.
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Trauma to the respiratory tissues following orotracheal intubation has not been extensively
documented in rabbits. In one study, tracheobronchial stricture formation was observed postmortem following anesthesia and blind orotracheal intubation, using an uncuffed, 2.5 mm inner
diameter endotracheal tube, of three clinically healthy rabbits (Grint et al. 2006). The authors
speculated that lesions could have been the result of trauma caused by movement of the
endotracheal tube during anesthesia or by chemical burns caused by disinfectant residues
following endotracheal tube sterilization. Another study observed gross and histopathologic
evidence of tracheal and laryngeal damage following blind or endoscopic-guided orotracheal
intubation of 15 rabbits, using either uncuffed or cuffed (2.5-3.5 mm inner diameter) endotracheal
tubes (Phaneuf et al. 2006). The authors suggested that tracheal vascular anatomy, tube movement
during mechanical ventilation, body position during anesthesia and repeated intubation attempts
may have been associated with tracheal mucosal injury in rabbits. A third study reported
significantly more tracheal damage in rabbits intubated using a blind orotracheal technique (2.03.5 internal diameter, cuffed endotracheal tubes) compared to rabbits where a supraglottic airway
device was placed (Engbers et al. 2017). Finally, a more recent study demonstrated a similar degree
of histopathological damage to laryngeal and tracheal tissues in 14 rabbits following endoscopicguided orotracheal intubation (using 3.5 internal diameter, cuffed endotracheal tubes) or placement
of a supraglottic airway device (Comolli et al. 2020). The authors of this study speculated that
tracheal lesions could have been pre-existing or possibly caused by inadvertent insertion of the vgel tip into the trachea during device placement.
Relatively few studies have investigated the occurrence of respiratory tissue damage
following orotracheal intubation and to the authors’ knowledge, none have quantitatively
correlated the number of attempts at tracheal intubation to the degree of tissue damage. Thus, the
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main objective of this study was to compare damage to respiratory tissues caused by blind and
endoscopic-guided orotracheal intubation of rabbits. A secondary objective was to correlate the
number of intubation attempts with degree of respiratory tissue damage. We hypothesized that
blind orotracheal intubation would cause a greater degree of damage to respiratory tissues and
would be associated with a higher number of intubation attempts compared to endoscopic-guided
orotracheal intubation. Additionally, we hypothesized that the number of intubation attempts
would be positively correlated to the degree of damage to respiratory tissues.
4.2. Materials and Methods
4.2.1. Animals
This study was approved by the Louisiana State University Institutional Animal Care and
Use Committee (Protocol No. 17-101). Twenty-four female, intact, New Zealand white rabbits
with a mean ± standard deviation (SD) age and weight of 2.10 ± 0.03 months and 2.2 ± 0.2 kg,
were used. The rabbits were considered healthy based on results of physical examination, complete
blood count and serum biochemical analysis. Upon arrival, rabbits were housed as a single group
in a large pen and allowed to acclimatize for at least 2 weeks prior to the experimental period.
They had free access to fresh water and Alicia or Alfalfa hay and were fed a commercial pelleted
diet (Country Acres Rabbit Pellet 16%, Country Acres Feed Company, MN, USA) twice daily.
Food, but not water, was withheld 12 hours prior to the experiment.
4.2.2. Experimental Design
Age, weight, heart rate (HR) and respiratory rate (fR) were recorded at the beginning of the
experimental period (T = 0) for each subject. Rabbits were assigned to undergo either blind
orotracheal intubation (group B; n = 12) or endoscopic-guided orotracheal intubation (group E; n
= 12) using a random number generator (www.randomnumbergenerator.com). Each rabbit was
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administered 0.1 mg kg-1 hydromorphone (Hydromorphone Hydrochloride; Hospira Inc., IL,
USA), 0.005 mg kg-1 dexmedetomidine (Dexdormitor; Zoetis Inc., MI, USA) and 7 mg kg -1
alfaxalone (Alfaxan multidose; Jurox Inc., MO, USA). The drugs were mixed together
immediately prior to injection and administered intramuscularly (IM) into the semimembranosus
or semitendinous muscles of the right or left hindlimb of each rabbit by a single investigator
(PQW).
Rabbits were placed in a small animal carrier, under observation for 10 minutes to allow
for onset of sedative effects. Subsequently, HR and fR were recorded (T = 10) and quality of
anesthesia was subjectively evaluated by the same investigator (SNR), using a semi-quantitative
rating scale modified from Raekallio et al. 2002 (Appendix A.1). The rating scale consisted of five
categories and their scores were summed for a total anesthesia score ranging from 0 to 12:
spontaneous posture (0-4), response to toe pinch (0-2), palpebral reflex (0-2), eye rotation (0-1)
and jaw tone (0-3).
Rabbits were positioned in sternal recumbency with the head and neck well extended.
Lidocaine was not used to desensitize the arytenoids to avoid confounding the results, as lidocaine
may exhibit an anti-inflammatory effect (Caracas et al. 2009). Orotracheal intubation was
performed by a single investigator (PQW) using an uncuffed, 2.0 mm inner diameter, murphyeyed endotracheal tube (Mallinckrodt Pharmaceuticals, MO, USA). For blind intubation, the
endotracheal tube was inserted into the oral cavity and advanced into the trachea once condensation
from respiration was visualized in the tube. For endoscopic-guided intubation, the endotracheal
tube was placed over a semi-rigid endoscope (FM-1.9X6 Micro-Endoscope; MDS-VET, Canada)
and was advanced off the endoscope and into the trachea, once positioned in the cranial trachea.
An intubation attempt was defined as the advancement of the endotracheal tube from the opening

47

of the mouth, at the level of the incisors, to the entrance of the larynx, which was identified via
palpation of the ventral neck region. Following an intubation attempt, end-tidal partial pressure of
carbon dioxide concentration (PE´CO2) was measured using a multiparameter monitor
(CARESCAPE monitor B850; GE Healthcare, Finland). Intubation was considered successful
when up to six consecutive PE´CO2 readings were present on the capnograph. If no capnograph
readings were present, intubation was considered unsuccessful and the process was repeated until
intubation was successful. Additional alfaxalone (3 mg kg-1) and dexmedetomidine (0.0025 mg
kg-1) were administered IM if quality of anesthesia was inadequate to allow for proper body
positioning or if excessive jaw tone, swallowing or tongue retraction were present to prevent
insertion of the endotracheal tube. If anesthesia and/or intubation quality were still insufficient,
additional alfaxalone (2 mg kg-1) was administered IM. Once successful intubation was achieved,
the number of intubation attempts was recorded and the quality of intubation was subjectively
evaluated by an investigator (PQW) using a semi-quantitative rating scale ranging from 0 to 3
(Appendix A.2).
Rabbits were connected to a Bain system and administered isoflurane (IsoFlo; Abbott
Laboratories, IL, USA) in 100% oxygen at 0.2 L kg-1 minute-1 for 2 hours. Rabbits were
instrumented for monitoring of HR and cardiac rhythm via electrocardiography, P E´CO2 and fR
via capnography, capillary hemoglobin oxygen saturation (SpO2) via pulse oximetry, systolic
(SBP), diastolic (DBP) and mean (MBP) arterial pressures via direct technique and rectal
temperature via the use of a thermistor (CARESCAPE monitor B850; GE Healthcare, Finland). A
22-gauge, 2.5 cm catheter (Sur-Vet Surflo ETFE; Terumo Medical Corp., NJ, USA) was
aseptically placed into the marginal vein of the left or right ear for administration of crystalloid
fluids (Lactated Ringer’s; Hospira, IL, USA) at a rate of 10 mL kg-1 hour-1. A 22-gauge, 2.5 cm
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catheter (Sur-Vet Surflo ETFE; Terumo Medical Corp., NJ, USA) was aseptically placed into the
auricular artery, in either the same or opposite ear containing the intravenous (IV) catheter, for
measurement of direct arterial pressure using a disposable pressure transducer system (Truewave
3.6M/12FT; Edwards Lifesciences, Germany) connected to a multiparameter monitor
(CARESCAPE monitor B850; GE Healthcare, Finland). The pressure transducer was aligned with
the glenohumeral joint (approximating the level of the heart) and zeroed prior to performing
measurements. Rabbits were allowed to spontaneously ventilate when P E´CO2 was between 35
and 45 mmHg. If hypoventilation (PE´CO2 > 45 mmHg) was observed, then positive-pressure
ventilation was applied using the reservoir bag of the Bain circuit. If hypotension (MBP < 60
mmHg) occurred, then rabbits were administered dopamine (Dopamine Hydrochloride; Hospira
Inc., IL, USA; 40-60 µg kg-1 minute-1) as a constant rate infusion (CRI). If hypotension persisted,
then dobutamine (Hospira Inc., IL, USA; 40-60 µg kg-1 minute-1) CRI was administered in addition
to dopamine. A combination of dobutamine and norepinephrine (Norepinephrine Bitartrate;
Baxter, IL, USA; 0.5-1.0 µg kg-1 minute-1) CRI was administrated for treatment of persistent
hypotension. Rectal temperature was maintained between 37-38°C using a forced-air warming
blanket (Bair Hugger; Arizant Inc., MN, US) placed underneath the rabbit. Cardiopulmonary data
was recorded every 5 minutes during the two-hour anesthetic period.
At the end of the anesthetic period, rabbits were euthanized with IV pentobarbital (FatalPlus; Vortech Pharmaceuticals, MI, USA) at a dose of 195 mg kg-1. Necropsy was immediately
performed for collection of laryngeal, tracheal and pulmonary tissues. Tissues were fixed in 10%
neutral buffered formalin and submitted to the Louisiana Animal Disease Diagnostic Laboratory
for gross and histopathologic examination. Tissues were processed and stained with hematoxylin
and eosin following standard procedures. The degree of histologic tissue damage was subjectively
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evaluated using a semi-quantitative scoring system modified from Phaneuf et al. 2006 (Appendix
A.3). Histologic tissue damage from samples of the cranial larynx (at the level of the vocal cords),
caudal larynx, cranial trachea (approximately 1 cm distal to the larynx) and caudal trachea (at the
level of the tracheobronchial bifurcation) of each rabbit were individually scored. Subsequently, a
total cumulative score was obtained by adding each independent score from each of the four
sections examined, ranging from zero to 16 for each rabbit. Scoring was performed by a veterinary
pathologist in training (MC) and by a board-certified veterinary pathologist (IML) who were
blinded to the treatment groups.
4.2.3. Statistical Analysis
Statistical analysis was performed using commercially available software (JMP Pro 15.0.0;
SAS Institute Inc., NC, USA). Weight and age were assessed by a student t-test and respiratory
and heart rates were evaluated with a mixed ANOVA with treatment, time and their interaction as
the fixed effects and each rabbit as the random effect. Anesthesia quality, intubation quality and
histopathology scores were tested against treatments via Mann-Whitney test. Additional drug
needed (Y/N) was evaluated using chi-squared test. The number of intubation attempts was fitted
with a Poisson regression against the treatment effect. Assumptions of the parametric models
(linearity, normality of residuals and homoscedasticity of residuals) and influential data points
were assessed by examining standardized residual and quantile plots and the normality of the
residual was confirmed with Anderson-Darling tests. The correlation of respiratory tissue damage
and the number of intubation attempts in the study was also evaluated using Spearman’s
correlation coefficient. A post hoc power analysis was performed with G*Power 3.1 (Faul et al.
2009) using the data of the number of intubation attempts and additional drug needed (Y/N) and
demonstrated that the group size was adequate to detect a significant difference between the two
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treatments, with 90% and 98% power, respectively. For all analyses, a value of P < 0.05 was
considered significant.
4.3. Results
Twenty-one rabbits completed the study without any adverse events occurring during the
anesthetic period. One rabbit in group E developed a ventricular arrhythmia which progressed to
severe bradycardia and hypotension despite treatment with dobutamine and norepinephrine.
Resuscitation was not performed, and this rabbit was euthanized at 1 hour and 36 minutes into the
anesthetic period. Two rabbits, both in group B, developed a light plane of anesthesia and began
moving causing extubation. The first rabbit extubated at 1 hour and 50 minutes into the anesthetic
period and was euthanized immediately as only 10 minutes remained until the end of the study
period. The second rabbit extubated at 1 hour and 15 minutes and was delivered isoflurane via a
tight-fitting facemask for the remainder of the anesthetic period. All 24 rabbits experienced
hypotension and were treated accordingly.
There were no differences in age or weight between rabbits in each treatment group. Heart
rates were higher at T = 10 compared to T = 0 (P = 0.04) with no difference between treatment
groups (Table 3). Respiratory rates were lower at T = 10 compared to T = 0 (P < 0.001) with no
difference between treatment groups (Table 3).
Table 3. Mean (± standard deviation) respiratory rate (fR; breaths minute-1) and heart rate (HR;
beats minute-1) data at baseline (T = 0) and 10 minutes (T = 10) following administration of
dexmedetomidine (0.005 mg kg-1), hydromorphone (0.1 mg kg-1) and alfaxalone (7 mg kg-1) of
rabbits undergoing blind (group B) or endoscopic-guided (group E) orotracheal intubation.

Group B
Group E

fR
T=0
108 (± 36)
119 (± 32)

T = 10

HR
T=0

T = 10

44 (± 15)
50 (± 20)

158 (± 20)
154 (± 29)

176 (± 25)
172 (± 47)
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The median (range) total anesthesia quality scores for groups B and E were 7.5 (6-8) and
7.0 (5-8) respectively (Table 4). Total anesthesia quality scores and individual values for each
category were not different between treatment groups. A higher number of rabbits in group E
(11/12 rabbits) required additional alfaxalone and dexmedetomidine to successfully intubate the
trachea compared to rabbits in group B (2/12 rabbits; P < 0.001).
Table 4. Median (range) anesthesia quality scores following administration of dexmedetomidine
(0.005 mg kg-1), hydromorphone (0.1 mg kg-1) and alfaxalone (7 mg kg-1) of rabbits undergoing
blind (group B) or endoscopic-guided (group E) orotracheal intubation. The maximum possible
score is 12.

Spontaneous posture
Response to toe pinch
Palpebral reflex
Eye rotation
Jaw tone
Total anesthesia score

Group B
4 (3-4)
0
1 (0-1)
0
2 (2-3)
7.5 (6-8)

Group E
4 (3-4)
0
1 (0-1)
0
2 (1-3)
7 (5-8)

The median (range) intubation quality scores were 2.5 (2-3) for group B and 3 (2-3) for
group E, and no difference was detected between treatment groups. However, a higher number of
intubation attempts was required for group B compared to group E, with median (range) intubation
attempts of 2 (1-8) and 1 (1-3) for groups B and E, respectively (P = 0.01).
Median cumulative histopathology scores and pooled scores for the cranial and caudal larynx and
trachea are presented in Figure 1. No inter-observer variability occurred between scores. The
median (range) cumulative histopathology scores for treatment groups B and E were 6 (3-10) and
6 (2-9) respectively. Location-specific histopathology scores, cumulative histopathology scores
and pooled scores were not different between treatment groups and respiratory tissue damage was
not correlated to the number of intubation attempts.
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Figure 1. Individual and cumulative histopathology scores following administration of
dexmedetomidine (0.005 mg kg-1), hydromorphone (0.1 mg mg kg-1) and alfaxalone (7 mg kg-1)
of rabbits undergoing blind (group B) or endoscopic-guided (group E) orotracheal intubation. A)
cranial larynx, B) caudal larynx, C) cranial trachea, D) caudal trachea, E) cumulative
histopathology score.
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4.4. Discussion
The main finding of this study is that both blind and endoscopic-guided orotracheal
intubation produced a similar degree of respiratory tissue damage despite the higher number of
intubation attempts needed with the blind technique.
In both groups, rabbits exhibited similar total anesthesia quality scores; however, 91.6% of
rabbits in group E required additional alfaxalone and dexmedetomidine to allow intubation
compared to only 16.7% of rabbits in group B. Rabbits requiring additional drugs initially
exhibited low intubation quality scores. However, following administration of additional
alfaxalone and dexmedetomidine, intubation quality scores increased and were similar between
groups. An adequate plane of anesthesia is necessary to attenuate laryngeal reflexes, provide
muscle relaxation, extrude the tongue out of the mouth and allow for proper positioning to facilitate
intubation. Also, the rabbits could only be intubated once the swallowing and coughing reflexes
had been abolished, emphasizing the need for an adequate anesthetic plane. In addition, these
results suggest that positioning associated with the intubation technique influenced overall success
rate of intubation. Endoscopic-guided intubation requires hyperextension of the head to allow
direct visualization of the larynx (Johnson 2010). Rabbits in group E appeared to exhibit
insufficient muscle relaxation and became sufficiently stimulated during hyperextension of the
head and neck, therefore necessitating administration of additional drugs. In comparison, rabbits
in group B required a lesser degree of head extension and did not become stimulated during
intubation despite requiring more attempts to successfully intubate.
Blind orotracheal intubation is frequently associated with repeated intubation attempts in
rabbits (Richardson 2015; Wenger et al. 2017). Rabbits in group B required a greater number of
intubation attempts compared to group E and had a wider range of values, with one rabbit requiring
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eight attempts. The blind technique often requires multiple attempts as correct placement of the
endotracheal tube is based on occurrence of breath sounds or condensation on the tube and not on
visualization of the glottis. In contrast, endoscopic techniques allow for direct visualization of the
glottis (Varga 2017), potentially increasing the success rate with fewer intubation attempts.
However, because endoscopic-guided intubation requires hyperextension of the head and neck
causing a higher degree of stimulation, a deeper anesthetic plane is required. Thus, higher drug
doses are required which could potentially increase risk of cardiorespiratory adverse effects.
Repeated intubation attempts have been implicated as a cause of laryngeal and tracheal
tissue damage in rabbits (Phaneuf et al. 2006; Engbers et al. 2017). However, none have
investigated a correlation between the number of intubation attempts and the degree of damage. In
the present study, total cumulative histopathology scores and range of values were similar between
groups despite group B having a higher number of intubation attempts. The highest cumulative
histopathology score was 10/16, occurring in a rabbit from group B who was successfully intubated
after only one attempt. In contrast, the highest number of intubation attempts was eight, occurring
in a rabbit from group B who obtained a low cumulative histopathology score of 2/16. It is not
known why such a difference existed; however, the results suggest that the number of intubation
attempts is not correlated with the degree of respiratory tissue damage.
All rabbits exhibited some degree of tissue damage, with similar scores reported between
the different tissue types. Histological damage to laryngeal and tracheal tissues were also
documented in the studies by Phaneuf et al. (2006), Engbers et al. (2017) and Comolli et al. (2020).
According to these authors, rabbits may be more prone to development of laryngeal and tracheal
lesions as a result of the highly vascularized mucosa (Phaneuf et al. 2006). Mucosal irritation due
to contact with the endotracheal tube may result in vascular congestion, edema and hemorrhage
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and varying degrees of these lesions were observed histologically in this study. An alternative
explanation for the presence of the observed tissue damage is that these lesions existed prior to
initiation of the study; however, a control group of non-intubated rabbits was not present in the
current study to allow comparison.
Intubation-induced lesions may progress over time, potentially resulting in stricture
formation (Nakagishi et al. 2005; Grint et al. 2006). In the present study, rabbits were euthanized
and the airway tissues were histologically evaluated two hours following intubation, which allows
sufficient time for the potential airway damage induced by intubation to develop histological
changes associated with acute inflammation (Bochsler & Slauson 2002). Following a traumatic
insult to a tissue, the initial neutrophilic infiltration generally occurs within 2 hours, followed by
peak infiltration in 4-6 hours, after which mononuclear infiltrates predominate and peak in 18-24
hours (Bochsler & Slauson 2002). The rabbits were euthanized two hours following intubation,
thus only the initial stages of the inflammatory response were evaluated in this study. In a clinically
applicable scenario, the extent of respiratory tissue damage may be more severe if an inflammatory
response has sufficient time to fully develop. Therefore, based on the results of this study, the longterm consequences of damage caused to laryngeal and tracheal tissues are not known and cannot
be predicted.
Alfaxalone can cause respiratory depression when administered IV or IM in rabbits,
especially when used in combination with other sedatives (Navarrete-Calvo et al. 2013; Huynh et
al. 2014; Bradley et al. 2019; Ishikawa et al. 2019). Thus, it is not surprising that a decrease in
respiratory rate was observed following administration of alfaxalone in this study, with some
rabbits exhibiting respiratory rates lower than the normal physiologic range of 30-60 breaths
minute-1 (Meredith & Campbell-Ward 2010). It is unclear if a resultant decrease in minute
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ventilation occurred causing hypoventilation and/or hypoxemia, as rabbits were not yet
instrumented for monitoring of SpO2 or PE´CO2. Previous studies have reported the occurrence of
hypoxemia in rabbits following administration of IM alfaxalone (Rousseau-Blass & Pang 2020;
Ishikawa et al. 2019). In the study by Rousseau-Blass and Pang (2020), 100% oxygen
supplementation via facemask resolved the hypoxemia but was associated with hypercapnia. Thus,
rabbits should be carefully monitored following alfaxalone administration and intubation is
recommended in anesthetized rabbits to provide oxygen supplementation and positive pressure
ventilation.
Alfaxalone has been shown to maintain cardiovascular stability and increase heart rate in
dogs but not cats at clinical doses (Muir et al. 2008; Muir et al. 2009; Okushima et al. 2015; LagosCarvajal et al. 2017; Lagos-Carvajal et al. 2020). In dogs, the positive chronotropic effect is
thought to be the result of a baroreceptor-induced increase in heart rate in response to a decrease
in arterial blood pressure (Okushima et al. 2015). However, whether a similar mechanism occurs
in rabbits has yet to be elucidated. In the current study, heart rates were higher following
administration of alfaxalone but remained within the normal range (180-300 beats minute-1)
reported for rabbits (Meredith & Campbell-Ward 2010). This is in contrast to studies reporting a
decrease in heart rate following alfaxalone administration in rabbits (Gil et al. 2012; Tutunaru et
al. 2013; Bradley et al. 2019). One explanation for this difference is that a higher dose of alfaxalone
was used in the current study, potentially causing a larger decrease in blood pressure and initiating
a reflex baroreceptor response. Hypotension commonly occurred; however, direct arterial blood
pressure monitoring was only initiated after rabbits were introduced to isoflurane anesthesia. Thus,
it is unclear if hypotension occurred as a result of the vasodilatory properties of the inhalant
anesthesia alone or if it was pre-existing to initiation of inhalant anesthesia as a result of alfaxalone

57

administration. Nonetheless, the fact that all rabbits became hypotensive is an important finding
as this could contribute to the higher mortality rate reported for rabbits if not treated appropriately.
The main limitation of this study was that a control group containing non-intubated rabbits
was not present, so it was impossible to know if there was any pre-existing respiratory disease.
However, it is the authors’ opinion that including a control group in this study did not fit within
the reduction principle of the humane use of animals in scientific research because it would have
required the euthanasia of rabbits for the sole purpose of examining the respirator tract. Instead,
we elected to reduce animal use by only comparing variables between the two intubation
techniques. The use of control animals could be replaced by examination of rabbits at
slaughterhouses or retrospective analysis of post-mortem reports. An additional study limitation is
that only young, apparently healthy New Zealand white rabbits were used, so the results cannot be
extrapolated to other breeds, older rabbits or rabbits with clinical illness.
In conclusion, a similar degree of respiratory tissue damage was observed following
orotracheal intubation using both blind and endoscopic-guided techniques. Blind intubation
required a higher number of attempts but was not correlated with a higher degree of tissue damage.
Endoscopic-guided intubation required the rabbits to be more sedate than for blind intubation. In
a clinical setting, this information provides novel evidence that the number of intubation attempts
may not contribute to the increase in anesthesia-related mortality seen in domestic rabbits as
suggested in the past by other authors. The level of anesthesia must be considered appropriate for
each intubation technique, perhaps not because of possible respiratory tissue damage but simply
for ease of intubation. Further investigation is warranted to determine the long-term consequences
of respiratory tissue damage caused by orotracheal intubation in rabbits.
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Chapter Five. Conclusions
Rabbits have one of the highest perianesthetic mortality rates reported in veterinary species
(Brodbelt et al. 2008). Several factors may contribute to this increased risk in rabbits including
drug-induced cardiovascular depression, lack of appropriate airway management due to
unsuccessful intubation, stress associated with handling, and underlying, subclinical respiratory
disease (Phaneuf et al. 2006; Grint & Murison 2008; Navarrete-Calvo et al. 2013; Engbers et al.
2017). In an attempt to reduce anesthetic-related mortality, there is a myriad of research
investigating improved intubation techniques that are simple and easy to perform, as well as
induction protocols using specific drug combinations in order to reduce the adverse effects
associated with using large volumes of a single drug.
Alfaxalone is a synthetic neuroactive steroid than binds GABAA receptors, resulting in
central nervous system depression (Lambert et al. 2003). Use as an induction agent in dogs and
cats is widespread and well-reported in the literature (Muir et al. 2008; Muir et al. 2009); however,
data on pharmacokinetics, safety and clinical efficacy is largely lacking in some species such as
rabbits. Intramuscular administration is advantageous, especially in easily stressed species such as
rabbits, because it allows dose-dependent sedation and anesthesia without handling the rabbit to
place an IV catheter. However, dose-dependent cardiorespiratory depression may also be seen with
IM administration, especially at high doses (Huynh et al. 2014). Currently, no study has
investigated the suitability of IM alfaxalone for orotracheal intubation of rabbits.
Orotracheal intubation in rabbits is technically challenging, often resulting in multiple,
unsuccessful attempts. It has been speculated that multiple intubation attempts can result in trauma
to the delicate laryngeal and tracheal tissues that comprise the rabbit upper respiratory tract;
however, there is a lack of scientific evidence in the literature to support this claim. Few studies
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have investigated the occurrence of respiratory tissue damage following orotracheal intubation in
rabbits, and none have attempted to correlate the number of intubation attempts to degree of tissue
damage.
Based on the lack of studies evaluating IM alfaxalone use for induction of anesthesia in
rabbits, one of the objectives of this thesis research was to determine the optimal dose of IM
alfaxalone in combination with dexmedetomidine and hydromorphone that would allow
endoscopic-guided orotracheal intubation in rabbits without causing excessive respiratory
depression and/or apnea. Similarly, due to lack of data surrounding potential damage to respiratory
tissues caused by intubation, another major objective of this research was to compare damage to
laryngeal and tracheal tissued caused by blind or endoscopic-guided orotracheal intubation. This
study also aimed to correlate the number of intubation attempts with the degree of respiratory
tissue damage.
In order to achieve the objectives of this thesis, two experimental studies were designed.
In the first study, 15 Mini-Lop rabbits received either 2, 5, or 7 mg kg-1 of IM alfaxalone in
combination with dexmedetomidine and hydrophone. Quality of anesthesia and intubation were
scored, and intubation was attempted using an endoscopic-guided technique. Quality of anesthesia,
quality of intubation, and intubation success rate all increased in a dose dependent manner, with
the highest alfaxalone dose producing the highest success rate of intubation (80% of rabbits).
Furthermore, no respiratory adverse effects were noted in any of the rabbits.
Higher doses of alfaxalone and/or dexmedetomidine may be necessary to increase the
success rate of intubation; however, higher doses of these drugs may result in clinically significant
cardiorespiratory depression. Previous studies have reported occurrence of respiratory depression
following IM administration of alfaxalone at similar doses used in the current study (Grint et al.
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2008; Navarrete-Calvo et al. 2013; Huynh et al. 2014; Ishikawa et al. 2019). In this study,
evaluation of respiratory function was based only on respiratory rate and the presence, or absence,
of apnea. Future studies are warranted to investigate the respiratory depressant effects of
alfaxalone in rabbits, using more sensitive methods of respiratory function monitoring (e.g.,
hemoglobin oxygen saturation, capnography, blood gas analysis).
In the second study, 25 New Zealand white rabbits were administered 7 mg kg-1 of IM
alfaxalone in combination with dexmedetomidine and hydrophone. Quality of anesthesia and
intubation were scored, and intubation was performed using either an endoscopic-guided technique
or a blind technique. Additional alfaxalone and dexmedetomidine were administered if intubation
was unable to be performed, and following successful intubation, the number of intubation
attempts was recorded. Rabbits were euthanized following two hours of general anesthesia, and
laryngeal, tracheal and pulmonary tissues were submitted for histopathologic evaluation. The
degree of tissue damage was scored for each tissue type in each rabbit.
A higher number of intubation attempts were required in rabbits undergoing blind
intubation compared to endoscopy-guided intubation. This result is not surprising as blind
orotracheal intubation is commonly reported to be technically challenging with a high rate of
failure (Grint & Murison 2008; Wenger et al. 2017). In contrast, endoscopy-guided intubation
allows direct visualization of the larynx, facilitating proper placement of the endotracheal tube and
allowing for a reduced number of intubation attempts. In addition, approximately 92% of rabbits
intubated using the endoscopy-guided technique required additional alfaxalone and
dexmedetomidine compared to only 17% of rabbits blindly intubated. These results suggest that
endoscopy-guided intubation was more stimulating to rabbits due to insufficient muscle relaxation.
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For example, endoscopy-guided intubation required a greater degree of head extension to properly
visualize the larynx, causing the rabbits to move warranting administration of additional sedatives.
Histopathological evaluation revealed no difference in the histopathology scores between
rabbits intubated using the blind or endoscopy-guided techniques, even though blind orotracheal
intubation required a higher number of intubation attempts. These results suggest that repeated
intubation attempts may not be associated with respiratory tissue damage and a subsequent
increase in the perianesthetic mortality rate of rabbits. In this study, rabbits were only anesthetized
for two hours, meaning that a fully developed inflammatory response may not have had sufficient
time to occur. Thus, the long-term effects on the respiratory tissues could not be evaluated. Further
studies are needed to assess the long-term damage to respiratory tissues and the potential clinical
consequences associated with repeated intubation attempts in rabbits.
In conclusion, this thesis research provides valuable information on the potential adverse
effects associated with repeated intubation attempts in rabbits. The results of this research suggest
that an increased number of intubation attempts may not be associated with respiratory tissue
damage and thus, it may not be a contributing factor to the increased perianesthetic mortality rate
seen in domestic rabbits. Furthermore, this research demonstrated that an anesthetic plane deep
enough to allow orotracheal intubation is possible following IM administration of alfaxalone in
combination with other sedatives such as α-2 agonists and opioids, without risk of clinically
significant bradypnea or apnea. In this study, the success rate of intubation increased in a dosedependent manner, with the 7 mg mg-1 resulting in a success rate of 80%. Further studies are
needed to evaluate this dose of alfaxalone in a clinical setting, both in healthy and sick rabbits.
The decision to perform intubation is based on various factors including type and duration
of procedure, available equipment, experience, size/breed of rabbit and overall health status. Based

62

on the results of this thesis research, several recommendations can be made with respect to
increasing the success rate of intubation and minimizing the risk of mortality in rabbits. First,
anesthetic events should be carefully planned beforehand, having all necessary equipment within
reach and additional anesthetic drug available if needed. In addition, a secondary plan of action
should be arranged should intubation ultimately fail and the clinician should designate a specific
time period in which intubation is attempted before implemented the secondary plan. Third, every
attempt possible should be made to minimize the stress of the rabbit in the preoperative period,
including minimizing handling using IM sedatives/anxiolytics and allowing the animal to achieve
maximal sedative effects in a quiet location. Drug selection should ideally involve agents that
provide adequate sedation/immobilization with minimal cardiovascular and respiratory depressive
effects, such as the protocol devised from this research. Forth, selection of intubation technique
should be based on clinician preference and experience. Intubation should be performed only by
experienced personnel taking care to avoid aggressive or forceful movements that could cause
trauma to the larynx and trachea. In addition, the rabbit should be preoxygenated via facemask
using 100% oxygenation prior to intubation and the clinician should ensure an adequate anesthetic
depth has been achieved to facilitated positioning and placement of the endotracheal tube.
Lidocaine should be administered to desensitize the arytenoid cartilages to prevent laryngospasm.
Finally, the rabbit should be appropriately monitored in the post anesthetic period for signs of
respiratory distress.
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Appendix. Semi-Quantitative Scoring System for Quality of Anesthesia,
Intubation and Respiratory Tissue Damage
Appendix A.1. Semi-quantitative scoring system adapted from a previously described scoring
system (Raekallio et al. 2002) to quantify the degree of anesthesia quality in rabbits. Scores for
each category were summed to determine the total anesthesia quality score for each treatment
group (maximum possible score of 12).
Category
Spontaneous
posture

Score
0
1
2
3
4
Response to 0
toe pinch
1
2
Palpebral
0
reflex
1
2
Eye rotation
0
1
Jaw tone
0
1
2
3

Description
Normal
Sternal recumbency, head up
Sternal recumbency, head down
Lateral recumbency, response to stimuli
Lateral recumbency, no response to stimuli
Complete withdrawal of limb
Partial withdrawal of limb
No withdrawal of limb
Strong
Weak
Absent
Central
Ventromedial
Unable to open mouth
Able to open mouth with strong resistance, unable to extrude tongue
Able to open mouth with minimal resistance, +/- tongue extrusion,
chewing/tongue retraction
Able to open mouth and extrude tongue with no resistance

Appendix A.2. Semi-quantitative scoring system to quantify the degree of intubation quality in
rabbits.
Score
0
1
2
3

Description
Swallowing and/or coughing not allowing intubation
Minimal swallowing and/or coughing not allowing intubation
Minimal swallowing and/or coughing allowing intubation
No swallowing and/or coughing allowing intubation
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Appendix A.3. Semi-quantitative scoring system adapted from a previously described scoring
system (Phaneuf et al. 2002) to quantify the degree of respiratory tissue damage in rabbits. Four
samples (cranial and caudal larynx, cranial and caudal trachea) from each rabbit were individually
scored and subsequently, a total cumulative score was obtained by adding each independent score
from each of the four sections examined (maximum possible cumulative score of 16).
Score Description
0
Within normal limits
1
Focal attenuation of epithelium
Heterophil exocytosis and/or few heterophils in lamina propria
2
Focal attenuation and/or erosion/ulceration affecting ≤ 5% of epithelial lining
Few heterophils within lamina propria and epithelium (exocytosis)
Mild or moderate edema of lamina propria
3
Focal/multifocal/extensive erosion/ulceration affecting 5-30% of epithelial lining
Heterophilic infiltration in lamina propria with cell debris/fibrin exudation
Focal/multifocal hemorrhages within lamina propria
Congestion/edema of submucosa or submucosal infiltration with heterophils and hemorrhage
4
Focal/multifocal/extensive erosion/ulceration affecting >30% of epithelial lining
Heterophilic infiltration in lamina propria with cell debris/fibrin exudation
focal/multifocal hemorrhages within lamina propria
Congestion/edema of the submucosa or submucosal infiltration with heterophils and hemorrhage
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